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ABBREVIATIONS

AIDS
ELISA
GC
KOH
HIV
IUD
LCR
LED
PCR
PID
RPR
RTI
STD
TPHA
VDRL

Acquired immune deficiency syndrome
Enzyme-linked immunoassay
Gonococcus (organism that causes Gonorrhea)
Potassium hydroxide
Human immunodeficiency virus
Intrauterine device
Ligase chain reaction
Leukocyte esterase dipstick
Polymerase chain reaction
Pelvic inflammatory disease
Rapid plasma reagin
Reproductive tract infection
Sexually transmitted disease
Treponema pallidum (syphilis) hemagglutination assay (for antibodies)
Venereal Disease Research Laboratory
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EXECUTIVE SUMMARY
Introduction and Overview
Interest in Reproductive tract infections (RTIs) has increased enormously, and
enthusiasm to act is palpable. A great deal of work must be done, however, before we will be in a
position to respond adequately to the problem. As a result, the Population Council convened a
meeting to examine how best to use available tools and information, learn about potential service
delivery approaches, and examine the direction of research. The meeting began with an
examination of what is known about the prevalence, distribution, determinants, characteristics,
and consequences of RTIs, as well as the common elements of an intervention framework. The
group then moved on to examine and discuss a range of key topics, as summarized below.
There are five basic approaches to diagnosing RTIs. These were discussed in terms of
their utility for diagnosing chlamydia, gonorrhea, genital ulcers, syphilis, herpes, chancroid, human
papilloma virus (HPV), trichomoniasis, candidiasis, and bacterial vaginosis (BV).
Quantitative research conducted in Mexico, Brazil, and China was presented. The
Mexico study, for example, found higher levels of RTIs than expected among women in both
hospital and community samples. Chlamydia rates among women in the hospital sample were
found to be as high as those found in a study of commercial sex workers in Mexico.
Qualitative research conducted in Egypt (Giza), Nigeria (Lagos), and India (Rajasthan)
was presented. The Rajasthan study, for example, focused on dhola Pani, the local term for white
discharge, in an effort to develop an ethnomedical model of this problem. Among other things,
women believe that poverty leads to physiological weakness, which in turn results in discharge.
Because they view the root cause of the problem as an economic one, they do not seek health
care.
Research on the utility of algorithms and risk screening in Khon Kaen province, Thailand
and Giza, Egypt was presented. In both cases, the risk factors investigated were found not to
correspond with clinical data, and, therefore, not to be predictive for RTIs. In Giza, for example, a
number of methods were used to determine the extent to which reports or observations of
symptoms, compared to medical examinations, could provide an estimate of RTI prevalence. It
was found that the presence of discharge—regardless of who reported it and whether or not it was
considered medically suspicious—was not predictive for RTIs.
Information presented on Vietnam and Bali, Indonesia made it clear that there is an
urgent need to develop multi-sectoral, interdisciplinary coalitions to overcome the obstacles to
effective RTI management. There are, however, many obstacles to effective coalition building. In
order to overcome some of these obstacles, the Ford Foundation in the Philippines is supporting
programs to bring activists from a wide range of backgrounds together to work on RTIs.
In spite of increasing consensus regarding the importance of addressing sexually
transmitted (STDs) and merging vertical programs and services, numerous questions arise when
it comes to investing resources in this area. Is it really necessary? Are STD programs costeffective? Can the impact of STD-related activities be measured? Is it feasible to implement all
the services necessary to ensure that an STD program is effective? Each of these questions was
addressed based on the outcomes of related research, which, it was noted, has yet to provide
sufficient information to overcome the skepticism. There is an urgent need to conduct further
research and to provide the skeptics with clear and precise information on the direct and indirect
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consequences of RTIs, and to illustrate the possibilities for integrating RTI interventions with
existing programs.
General obstacles related to work in the area of RTIs include lack of awareness of the
problem and the limited power of women in society. Obstacles to developing research include
difficulties in setting local priorities due to lack of dialogue with or input from the community and a
lack of alliances between researchers and service providers. Proposals for overcoming some of
these obstacles were presented, as were the specific obstacles confronted by RTI research
conducted in Rajasthan, India and Kenya.
Priorities for future research and programming included: further research on the scope
and consequences of RTIs; integration of RTI services with other types of health care; continued
investment in female-controlled technology; research on gender and power relations and their
relationship to STDs and related protective measures; and research on appropriate low-cost
diagnostics and screening tools.
There was broad agreement among participants that candida, BV, and trichomonas are
the most widespread infections. These infections are relatively easy to deal with, but are not the
most serious. This poses a difficult question: what does one do when the infections that are
easiest to treat pose the least serious health problems? There was also broad agreement that
providers must be able to diagnose and treat RTIs in order to provide contraceptive services of an
acceptable quality.
The group heard a great deal about the complex issues surrounding RTIs. While more
questions were raised than conclusions reached, the meeting helped to facilitate a move forward
in dealing with this serious public health problem.
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INTRODUCTION AND OVERVIEW
Beverly Winikoff
The Population Council
New York, New York

As the title of this meeting implies, we did not gather to discuss a finished product, but
neither are we just beginning to look at the issues surrounding reproductive tract infections (RTIs).
These issues are so complex that we did not want to wait for the all of the research that is
underway to be completed prior to examining the direction of our work in this area. The timing of
this meeting is particularly apt: interest in RTIs is becoming widespread and enthusiasm to do
something about the problem—and to do something soon—is palpable. There is, however, much
more work to be done before we will know how to respond adequately to the problem.
From its inception, the Population Council's Robert H. Ebert Program on Critical Issues in
Reproductive Health and Population has been interested in the subject of RTIs and sexually
transmitted diseases (STDs). The Program was established in 1988 to bring attention to serious
and understudied—and often controversial—issues affecting reproductive health. The subject of
RTIs is clearly relevant to the program's mandate for several reasons, including the following:
The problem is enormous The World Health Organization (WHO) estimates that 100
million acts of intercourse take place daily and that these result in the transmission of an
estimated 356,000 sexually transmitted infections per day.
The problem is poorly defined Until recently, there has been very little qualitative or
quantitative research on the extent and dimensions of the problem.
The problem relates to the provision of contraceptive services It is highly relevant to the
Population Council and other sister institutions working in the field of family planning and reproductive health.
The problem is controversial Concerns aroused by discussions of RTIs, and especially
of STDs, are emblematic of gender and power inequities, subjects which generate controversy.
At the same time, and more urgently, a number of different forces have focused interest
on RTIs. Several well-publicized studies have demonstrated that levels of infections are alarmingly high, surprising both women's health advocates and the public health community. The
increased focus on quality of care in family planning also brought attention to RTIs, reminding us
of issues surrounding a health care provider's ability to diagnose infections in family planning clients, appropriate use of IUDs, and the risk to a client of iatrogenic infections. The fact that STDs
are a known co-factor in AIDS transmission has also focused attention on the topic. Finally, over
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the months since the International Conference on Population and Development (ICPD) held in
Cairo in September 1995, there has been accelerating interest in the idea of reproductive health.
Nonetheless, while there is strong impetus to develop strategies to deal with RTIs, there
are great obstacles to doing so. Related services are expensive and difficult to provide. They
require a range of diagnostic tests and equipment, specific and complicated training, and drugs
that may not normally be available in a clinic setting. In addition, clinics would have to deal with
the complex issues of partner identification, notification, and treatment. We also lack the technical tools for treatment, screening, and diagnosis of RTIs in resource-constrained environments. A
further impediment to addressing RTIs is that these services are currently orphan services. Providers fear that existing services will be stigmatized if RTI treatment is offered alongside family
planning services, for example, because RTIs are associated with STDs, even when they are not
sexually transmitted. An increased focus on RTIs can also be threatening to providers of IUDs
and hormonal contraceptives that do not protect against sexually transmitted infections (oral
®

contraceptives, NORPLANT implants, Depo Provera). The most significant obstacle to
addressing RTIs is the implied social critique that accompanies the issue of RTIs and the gender
power questions this problem raises. Such questions, some of which are noted below, may
threaten traditional political and social structures.
·

Should men shoulder the blame for women's health?

·

Is it fair—or is now the time—to examine traditional male behavior and make
normative judgements or propose change?

·

Is there a need to make men do things they might not otherwise choose to do,
including using condoms?

The issue of RTIs raises questions regarding widely-held assumptions about sexuality.
Not surprisingly, talking about sexual encounters makes people uncomfortable. The data
available indicate, however, that often, sexual encounters are not voluntary, pleasurable, or safe
for women, who may lack control over the number of partners they have, the timing of sexual activity, men's behavior, and contraceptive use. Confronting the problem of RTIs requires facing
these troubling issues.
Despite the difficulties outlined above, we have begun to study RTIs in both quantitative
and qualitative ways, as the agenda of this meeting indicates. We have tried to determine if it is
important to quantify the extent of the problem, and, if so, among which groups? The general
population? Particular regions? We have also examined the utility of community and individual
perceptions gathered through qualitative research. Whose perceptions are we interested in?
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Women's? Men's? Special groups'? Special regions'? How can we best use the information
gathered through both qualitative and quantitative research? For program planning? For political
ends? For advocacy? To improve research?
We are also looking very carefully at various prevention strategies. While we have some
guideposts, we do not yet have a clear road map on this issue. There are numerous areas that
demand further exploration, including: the role of information, education, and counseling; quality
of care and provider practices; the extent to which condom promotion is a realistic prevention
strategy; and the extent to which women's empowerment—including access to resources, legal
rights, and their ability to make choices and participate equally in the nature of and
decisionmaking regarding their relationships with men—can be seen as a prevention strategy.
We also need to examine treatment as a prevention strategy, in that it protects the individual and
the community and may prevent other diseases, such as AIDS. We face a major dilemma in this
area, and must determine who should be treated, and when they should receive treatment. We
must also examine community and individual definitions of illness, and the role of these definitions
in the development of prevention and treatment strategies.
There are a few things that we can say with confidence. We know that there exists
widespread incidence of RTIs and that the specific patterns of these infections vary: some are
STDs, some are not; and some are more serious than others. We know that we disagree on the
infections that merit the most focus, and why. There is also a lack of understanding among
women about the etiology, seriousness, and range of infections. In addition, clinicians lack an
understanding of the problem and do not have the ability to provide appropriate information or
detect cases. Finally, we know that we have little or no information on program approaches and
that we are unable to give clear advice to policymakers and program managers.
As we convene this gathering to discuss this complicated issue, we hope to:
·

examine how to use the tools and information available from quantitative and
qualitative research in both advocacy and program planning;

·

learn about the approaches to service delivery that may be most fruitful; and

·

examine whether we should change our direction and/or the type of the research
we are conducting on this topic.

In some ways, this meeting is part of an ongoing internal discussion. The agenda
focuses on a number of collaborative projects in which the Council has participated, although
others will also be discussed. We hope that by sharing our results and thinking to date we will
help others who also struggle with these issues, and we are sure that your contributions will help
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us immeasurably as we move forward with our own work on RTIs.
Christopher Elias
The Population Council
Bangkok, Thailand

While there are many unanswered questions regarding reproductive tract infections
(RTIs), interest in the issue has increased and our thinking has evolved considerably over the last
several years. A broad outline of issues related to RTIs, which I hope will help start our
discussions, is outlined below. The remainder of the meeting will shed further light on these
issues and give us an opportunity to discuss their implications for programs.

Definitions
There are three types of RTIs:
1.
Sexually transmitted diseases (STDs).
2.

Endogenous infections: infections, such as bacterial vaginosis and candidiasis,
caused by overgrowth of microorganisms normally present in the vagina.

3.

Iatrogenic infections: infections associated with medical procedures, such as
unsafe abortion, IUD insertion, and labor and delivery practices.

As this list indicates, RTIs have different determinants. They also have different consequences. As a result, they require different intervention strategies.

Prevalence studies
Prevalence studies have found that RTIs are extremely common and that prevalence
rates are extremely variable. There is no readily discernible pattern of prevalence to help us
determine which women are most in need of services. These studies have highlighted a number
of problems, including the fact that many infections are asymptomatic. In addition, perceptions of
symptoms do not correspond well with recognizable clinical syndromes as defined by biomedical
paradigms. That is, a woman in a village may have a name or a way of describing her illness that
may or may not have very much to do with its clinical name, for example gonorrhea, chlamydia, or
syphilis. We have also learned that clinical and lab results vary tremendously in terms of their
diagnostic utility, revealing differences in diagnostic criteria as well as clinical acumen.
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Consequences of RTIs
RTIs have a broad range of consequences for both women and children. Women face
possible infertility, ectopic pregnancy, chronic pelvic pain, and a higher risk of HIV infection; and
infants exposed to congenital infections (gonorrhea, chlamydia, syphilis, herpes simplex) may
develop serious problems.
RTIs also have an impact on family planning programs. By compromising fertility,
pregnancy outcome, and child survival, they may decrease the demand for contraception. If RTIs
are seen as possible side effects of contraceptives, women may not use them. In addition, there
are real and perceived associations between RTIs and particular contraceptive methods that may
result in client or provider bias against these methods. Finally, while many infections are
asymptomatic, women often come to family planning clinics with complaints related to RTIs when
they are symptomatic. If providers are unprepared to deal with the complaint that prompted the
visit, because they are not trained to do so or do not have the necessary equipment or supplies, it
diminishes their credibility with the women they serve, in addition to jeopardizing the health of
women who do, in fact, have infections.

Determinants of RTIs
The following framework, which was developed by Judith Wasserheit and Ward Cates,
helps us to understand the range of factors that affect RTI patterns.
Microbiological determinants influence an individual's likelihood of having an RTI.
Changes in vaginal flora, and the existence of other RTIs, may be important. Hormonal factors
(including cervical ectopy and mucous), seminal fluid, and changes in the immune system (related
to pregnancy or HIV, for example) also influence an individual's susceptibility to infections.
Personal environments also affect the likelihood of infections with certain organisms. A
woman's sexual behavior—including her number of sexual partners, age of coital debut,
participation in commercial sex, and whether her partner has intercourse with commercial sex
workers—can make her more susceptible. Her health behavior—including use of condom/ barrier
methods, oral contraceptives, IUDs, intravaginal preparations, and vaginal douches—also
influences her susceptibility. Circumcision also affects individuals' risk of infection. While the
effect of male circumcision is protective, particularly for viral infections such as HIV and chancroid,
some researchers have raised the concern that female circumcision may increase the risk of
some infections. Finally, whether and how infected individuals seek help when they feel that they
have an infection is also an influential factor.
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Macro-environmental factors—including socio-economic, political, demographic,
geographic, and technological factors—also influence the transmission, identification, and
treatment of infections.

Framework for intervention strategies
Designing and implementing appropriate services will require the coordination of diverse
inputs, including personnel, financial resources, and service structures, the availability and pattern
of which are highly variable. There are, however, common elements for an intervention
framework, as outlined below.
Primary prevention of infections Strategies to prevent STDs include delaying coital debut,
reducing the number of sexual partners, and promoting condoms; preventing endogenous
infections by improving knowledge of physiology and hygiene, and encouraging appropriate use of
antibiotics; and preventing iatrogenic infections by improving the quality of abortions, IUD
insertion, and childbirth practices.
Identification and/or treatment of established infections While many women are
asymptomatic, many of those with symptoms do seek help from service providers. Standardizing
case management is very important, but in doing so, we should think critically about the riskassessment component of some of the algorithms being recommended. We also need to screen
for asymptomatic infections. Diagnostic tests for RTIs tend to be expensive and would have to be
rationed, but we could use selective case finding for high-risk populations. We need to move
beyond the question of "Do we notify partners?" to determining how to do so in a culturally sensitive way. Mass or epidemiological treatment has also been suggested as an intervention strategy,
but it requires evaluation, the latter of which must include an evaluation of the costs of emerging
antibiotic resistance in a community.
Minimizing the complications of infection This approach is costly, but also has a potentially high yield. Its stakes are also higher, insofar as it implies dealing with infections that exist
and are progressing or have progressed to a later, more critical phase. Specifically, we can work
to improve:
·

the management of septic abortions;

·

early identification and treatment of pregnant women with syphilis;

·

alarm and transport mechanisms for the management of ectopic pregnancy;

·

infertility management; and
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·

cervical cancer screening and management.

The above provides a broad overview of the issues surrounding RTIs, which we will discuss in
more detail as the meeting progresses.
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UPDATE ON STD DIAGNOSIS
William M. McCormack
State University of New York
Health Science Center
Brooklyn, New York

There are five basic approaches to diagnosing infection:
1. visualizing the organism directly;
2. using antibody tests that measure the body's response to the organism;
3. growing the organism using a culture preparation;
4. searching for antigens using non-amplified techniques; and
5. searching for antigens using amplification.
Specific organisms can be diagnosed by using more than one of the approaches listed
above. Chlamydia and Human papilloma virus (HPV) are the most complex infections to
diagnose. A summary of the ways to diagnose various reproductive tract infections (RTIs) is
provided below.

Chlamydia
Chlamydia can be visualized, but no one uses this method of diagnosis. Similarly, there is
no value to using an antibody test. Currently, the "gold standard" for diagnosing chlamydia is to
use a culture preparation. This, however, is expensive and complicated. DNA probes have been
available for about a decade and while they are probably about 80 percent as sensitive as culture
1

preparations, they are about 99 percent specific . Amplified antigen detection tests are about 15–
20 percent more sensitive and specific than culture techniques. These new amplified antigen
detection tests, such as polymerase chain reaction (PCR) and ligase chain reaction (LCR), can
pick up antigens in urine, which is important from a public health perspective in that it implies that
screening can be conducted in a wide variety of locations. While these tests currently cost about
US$20 each, they will be cheaper in volume.

Gonorrhea
A gram stain is a very good diagnostic test for gonorrhea in men. For both men and
women, with or without symptoms, culture is an excellent diagnostic test if an incubator,
1

Ninety-nine percent specificity is an important clinical concept. It means that if you test 100 women who are
negative, 99 of them will have negative test results, or, if you test 100 women who are negative, 1 will test positive.
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technician, and other necessary supplies are available. While there is not, given the above, a
compelling reason for developing non-culture tests, industry has developed them, and they are
marketed in tandem with chlamydia tests.

Genital ulcers
In most parts of the world, genital ulcers are the result of syphilis, herpes, and/or chancroid. Tests to diagnose these illnesses in the ulcer phase are only available on a limited basis
and are imperfect, at best.

Syphilis
There is a dark-field test for primary syphilis, but it requires a dark-field microscope and
technician, both of which are very expensive. Direct fluorescent antibody staining is possible, but
also requires a microscope and technician. No antigen detection tests are on the market. In all
stages, syphilis is usually diagnosed by serologic tests.

Herpes
The herpes virus can be visualized using a "Tzanck prep," which involves staining for the
strange-looking cells that it induces. This is an insensitive test, however, and not widely used.
Culture is the "gold standard" for diagnosis of herpes lesions, but is expensive and requires a lab.
Antigen detection tests are available, but are less sensitive than culture.

Chancroid
It is possible to look for chancroid organisms using a gram stain, but this is insensitive
and not widely used. No useful blood test exists. Chancroid can be grown, but this requires
special media and labs. Antigen detection techniques are not yet available.

Human papilloma virus (HPV)
We are currently in the initial stages of understanding the HPV organism. It cannot be
visualized directly. You can look for changes in cells, but there is no blood test available and the
organism cannot be grown in culture. It can be categorized on the basis of DNA probes. Other
diagnostic tests are under development that will improve on the DNA probes.
We should not be making HPV treatment decisions based on the results of inadequate or
inaccurate diagnostic tests. The treatment options available are not only ineffective, but also
potentially harmful. Currently, HPV management relies on Pap smears. Diagnosing HPV
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requires looking for changes brought on by the organism instead of the organism itself. Patients
who have abnormal Pap smears, most of which are due to HPV infection, should be referred to a
gynecologist.

Trichomoniasis
Trichomonas vaginalis can be visualized in direct wet preparations. No useful blood test
exists. The organism can be cultured and cultures add 10–15 percent to the yield over wet
preparations, particularly in asymptomatic individuals. There are no marketed antigen detection
tests for trichomoniasis, but they are under development.

Candidiasis
Candida organisms can be seen in wet preparations or in gram stains of vaginal material.
Sensitivity, however, is only 60 percent when this approach is used. No useful blood test exists.
Candida organisms can be grown in culture, which is the "gold standard" for their diagnosis. Antigen detection tests have been developed for candida, but none of those that are presently on the
market are useful for the diagnosis of vulvo-vaginal candidiasis.

Bacterial vaginosis
Bacterial vaginosis is the absence of normal vaginal flora or the replacement of normal
vaginal flora with abnormal vaginal flora. Clinical diagnosis involves measuring vaginal pH, detecting abnormal odor after alkalinizing the secretions, and noting whether the secretions are
abnormal in appearance. This approach requires a microscope, but could be used in any area of
the world. There has been interest in developing antigen detection tests.

COMMENTARY
Vilma Barahona
Hospital General Aurelio Valdivieso
Department of Clinical Pathology
Oaxaca, Mexico

Reproductive tract infections (RTIs) are extremely common and can have serious consequences for the health and social well-being of women in developing countries. They are, however, preventable, and can be treated. Because Pap smears are relatively cheap in the developing
world, they are a useful means of screening for reproductive morbidity. Risk for or presence of
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RTIs should be taken into account in the development and delivery of all services related to family
planning, safe motherhood, and AIDS prevention.
In addition, research on RTIs must take into account the conditions in which women live
and the economic, political, cultural, and social context that defines the relationships between
women and men. In Mexico, for instance, as poverty becomes more widespread, an increasing
number of men from rural areas migrate to the north and to the U.S. in search of work, and more
women are forced to trade sex for money in order to survive. These problems increase the
prevalence of RTIs, as well as AIDS.
Like most of my colleagues, I read journals and attend international conferences. Upon
returning home, however, I am faced with the reality of old and obsolete machines, a lack of office
and laboratory equipment, a scarcity of well-trained technicians, and many other constraints. I am
forced to identify other means to carry out my work within these constraints, which is a difficult and
tiring task.
In summary, when considering advances in technology and research, we also need to
consider ways to facilitate technology transfer at a reasonable cost. We must keep in mind that
the transfer of new information and technology is not automatic, and is often hampered by socioeconomic conditions.
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DEFINING THE SCOPE OF RTIS: QUANTITATIVE RESEARCH
Kathryn Tolbert
The Population Council
Mexico City, Mexico
Introduction
The work I will report on represents an ambitious first project for the Health Research Center
of Comitán. For the Population Council, it has served as a pilot study for a larger, comparative
study of reproductive tract infections (RTIs) in two other states in Mexico. Ultimately, we will have
data from three states on the prevalence of RTIs, and on aspects of sexual behavior which may
relate to the presence of infections.

Quantitative study
The clinical research was conducted at the Comitán general hospital and laboratory. Both
the general medicine outpatient clinic (GMC) and the gynecology clinic (GC) contributed patients
for screening. A total of 416 women seeking a range of services from the two clinics were
studied. Enrollment was undertaken through clinical census. To be enrolled, women needed to
be over 15 years of age and attending one of the clinics. Pregnant women were not excluded, but
the data collected on these women were analyzed separately. An additional 93 women who had
participated in community development projects in four periurban communities around Comitán
were also studied, as were 108 women from a nearby collective farming community (ejido).
These women represented a convenience sample, and were enrolled by invitation. The study was
explained to the women and they were told they would be given a physical exam and Pap smear,
informed of the results, and, if an infection was detected, be treated. Their consent was obtained
and noted.

Methodology
A short questionnaire was administered to gather demographic, health, and risk
information. The women were also given a pelvic exam and Pap smear. Samples were taken
and the results of the physical exam were noted on each patient's record. Diagnostic tests were
performed for the following:
·
·
·
·

Syphilis, by VDRL test
Gonorrhea, by immediate microscopic exam and culture
Trichomoniasis, by immediate microscopic exam
Chlamydia trachomatis, by ELISA test on endocervical brushings and cell culture
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·
·

Moniliasis, by immediate microscopic exam
Bacterial vaginosis (a syndrome of profuse vaginal discharge with a characteristic
odor, a pH of less than 5, and large numbers of white cells and "clue cells"), by
microscopic examination

Because of budget limitations, only a subsample of each group was tested for chlamydia.

Results
There were no significant differences among the women from the two clinics in terms of
age, schooling, civil status, age of menarche, age at first pregnancy, or number of living children.
There were, however, differences in pregnancy status: 51 percent of the women attending the
GMC were pregnant, compared to 15 percent of those attending the GC (see Table 1).
Table 1
Comitán General Hospital Population
Clinic

Mean
age

School
(none or
incomplete)

Civil
status

Married

In union

Average
age at
first
pregnancy

Average
number of
live
children

Pregnant

GMC
(n=250)

30

73%

66%

29%

18.6

3.1

51%

GC
(n=166)

33

75%

63%

28%

18.8

3.5

15%

The women who attended the clinics came almost exclusively for reproductive health
problems. They complained of pain, menstrual difficulties, postpartum difficulties, pregnancyrelated concerns, and symptoms that might indicate the presence of RTIs, such as burning,
itching, ulcers, "bumps," and lesions in their lower reproductive tract.
The levels of RTIs found in the sample of 416 women who attended the Comitán General
Hospital clinics were higher than expected, with more than 50 percent of women testing positive
for one or more pathogens. Of particular interest was the fact that 12.4 percent of the subsample
of 145 women tested for chlamydia were found to have the infection. This is the same level of
prevalence as that found in a sample of commercial sex workers in Chiapas (Tapachula) by a
Health Secretariat study. Both gonorrhea and syphilis rates are low (there were no cases of
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syphilis), perhaps representing the ready availability of antibiotics (over-the-counter without
prescription) and their frequent use for respiratory and intestinal infections.
Specific infection rates are reported separately for pregnant and non-pregnant women.
The pregnant women were slightly more educated than the non-pregnant women, with 63 percent
reporting no schooling or incomplete primary education. This is probably due to the fact that the
non-pregnant group includes the older women in the study, who probably have less education
than the younger women due to advances in extending education to women in the last two
decades. No other socio-demographic variable was significantly different for pregnant women.
Infection rates, and particularly sexually transmitted infection rates, do not vary
significantly between the clinics (Table 2). Pregnant women, however, differ significantly from
their non-pregnant counterparts in this regard, with a higher rate of Candida infections and a
surprisingly low rate of chlamydia infection.
Table 2
Percentage of Women with Infection (by pathogen):
Comitán General Hospital Outpatient Sample
GMC Non-pregnant
(n=123)

GC Non-pregnant
(n=140)

Pregnant (both sites)
(n=153)

0

0

0

2.5 (n=120)

2.1

0

Trichomonas

5.7

2.1

3.8

Candida

15.4

21.4

33.1

Bacterial vaginosis

28.5

27.1

25.5

15.6 (n=45)

16.7 (n=60)

2.5 (n=40)

Pathogen
Syphilis
Gonorrhea

Chlamydia
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Table 3

In the periurban/ejido group (n=201), only
three women were pregnant, so analysis was not

Infection Rates Among Periurban
and Ejido Women

conducted separately by place of residence. One of
the three pregnant women tested positive for

Pathogen

chlamydia. The infection rates for this group are
presented in Table 3.
Additional findings from the physical exam

Infection Rates

Syphilis

0

Gonorrhea

0

Trichomonas

18/201 = 9%

are also troubling. In the hospital sample, four
cases of previously detected invasive cancer, and
six cases of carcinoma in situ, were noted. In the
community sample, two cases of carcinoma in situ

Candida

12/201 = 5.8%

Bacterial Vaginosis

76/201 = 37.8%

Chlamydia

27/141 = 19.1%

were detected.

In summary, the data collected indicate the following:
·
·
·
·
·

·

Infection rates are high among these women (particularly for candida, bacterial
vaginosis, and chlamydia)
Cervical ulceration is common, and vaginal condyloma rates are high among the
women in the community sample
There is substantial unanimity of results between the two recruitment sites (hospital
and community samples)
Where it could be measured with sufficiently large numbers, pregnant women seem to
have more candida infection and less chlamydia infection
Chlamydia infection rates are much higher than predicted based on other developing
country prevalence data and on the results of a study of a high-risk sample
(commercial sex workers) in Mexico
In general, women in the community sample had greater infection levels for each
pathogen, despite the fact that they had similar socio-demographic characteristics
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Eugenio Pacelli de Barreto Teles
Federal University of Ceara
Department of Community Health
Fortaleza, Brazil

In our study, we examined 407 sexually active women who were attending the family
planning clinic at the State University of Campinas to initiate use of a contraceptive method. The
clinic is well known to be the only public facility in the city that provides intrauterine devices (IUDs),
and is therefore heavily oriented toward IUD service delivery. To some extent, women probably
self-select before attending this clinic, because they know that the clinic will not provide IUDs to
women who are not in monogamous relationships.
All patients enrolled in the study were screened by clinical exam, history, and laboratory
findings. Researchers used saline wet mount to diagnose bacterial vaginosis (BV), candida, and
trichomoniasis; gram stain to diagnose gonorrhea, BV, candida, and trichomoniasis; Pap smear
for human papilloma virus (HPV); culture for gonorrhea; and fluorescent test for chlamydia.
Prevalence rates are indicated in Table 1. The clinical and medical history was used to exclude
women who were felt to be inappropriate candidates for IUD use based on the likelihood of
sexually transmitted genital infection. If cultures later revealed that an IUD had been inserted
inadvertently into a woman with a pre-existing infection, the woman was called as soon as the
results were known, and treated. Some women returned to the clinic with symptoms of infection
prior to hearing of the laboratory findings.
Table 1
Reproductive Tract Infection Prevalence
% Prevalence
of infection
(all women)
(n=407)

% Prevalence of
infection among IUD
acceptors
(n=327)

% Prevalence of infection
among all non-IUD family
planning acceptors (n=80)

B. vaginosis

25.8

25.1

28.8

Chlamydia

6.7

5.9

10.0

Candida

2.2

2.4

1.3

Trichomoniasis

1.7

2.1

0.0

HPV

1.0

1.2

0.0

Gonorrhea

0.0

0.0

0.0

No infection

64.1

66.0

62.0
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When clinical and medical histories were compared to the laboratory results, the clinical
predictors were found to be surprisingly inadequate. Of all the reproductive tract infections (RTIs)
examined, clinical diagnosis of BV resulted in the fewest false positives by a large margin.
Overall, however, the efficacy of clinical diagnosis was unsatisfactory; the indicators tended to be
of low sensitivity and to generate high proportions of false positives (see Table 2).
Table 2
Accuracy of the Clinical Diagnosis of Genital Infections
Infections

Sensitivity

Specificity

False +

False -

Chlamydia

7.4

92.8

93.1

6.7

Trichomoniasis

42.9

96.5

82.4

1.0

Candida

33.3

97.0

80.0

1.5

B. vaginosis

41.0

90.7

39.4

18.5

The prevalence of genital infections among IUD acceptors was lower than among the
acceptors of other methods, although this was not statistically significant. Out of the 327 IUD
acceptors, 19 tested positive for chlamydia, two of whom developed clinical signs of pelvic
inflammatory disease (PID). One of these women was treated with drugs, but retained her IUD;
the other was treated with drugs and had the IUD removed.
We found that, despite relatively little "high risk" sexual behavior, new acceptors of
contraception had a significant prevalence of chlamydial cervicitis and were not easy to identify
through any means other than laboratory examination. This underscores the need for cheaper
and simpler diagnostic tests, but also suggests a simultaneous need to explore alternative options
for improving the safety of contraceptive service provision.
Joan Kaufman
Abt Associates, Inc.
Cambridge, Massachusetts

The study on which I will report was carried out in collaboration with Professor Yan Liqin
and her colleagues at Kunming Medical College in Kunming, the capital of Yunnan province,
China. We decided to conduct the study because previous research had found high rates of
vaginitis and cervicitis in Yunnan, suggesting underdiagnosis of reproductive tract infections
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(RTIs). Yunnan, which is located in southwest China, borders Burma, Laos, and Vietnam.
Other studies and factors point to high RTI prevalence in China. I will discuss some of
these briefly before moving on to our results of the study in Yunnan. In 1992, the Ford Foundation
carried out a reproductive health survey of 8,500 women in China, which revealed high rates of
self-reported vaginitis and vulval itching. National statistics indicate that more than 40 percent of
women who use contraceptives, or 60–70 million women, use IUDs and abortion rates are high as
well, providing an opportunity for iatrogenic infection at lower level clinical facilities, where many of
these procedures are performed. Sexually transmitted disease (STD) rates are rising nationwide,
and especially in urban areas. Within the last few years, sexual transmission of human
immunodeficiency virus (HIV) has increased. China's tremendous population movements from
the rural areas to the cities and migrant workers moving from city to city also influence HIV
prevalence patterns. Yunnan, however, accounts for 80–90 percent of China's HIV, mainly
concentrated among injected heroin users near the Burmese border.
The Yunnan study mandate was two-fold. We began by compiling and reviewing existing
information on RTIs in China from a variety of sources. Although Ministry of Health officials often
say there are no cases of pelvic inflammatory disease (PID) or STDs in the country, the incidence
of STDs has been rising, as noted above and as many small, but unconnected, studies reveal.
Our literature review compiled existing information on RTIs and STDs in China, and we tried to
answer several questions, including: What has been done in China regarding RTIs and STDs?
What services are available? Are RTI treatments standardized? How much do they cost?
We found that, as

Table 1

suspected, rates of
STDs For Which Different Hospitals/Health
Centers Have Testing Capacity

cervicitis in China are high.
In a variety of studies
conducted in different areas

Items

Province

City/
County

Township

Village

of the country, rates of
Trichomonas

100%

76.1

--

--

Candida

100%

76.1

--

--

percent. We also learned

Gonorrhea

100%

61.8

--

--

that there is little capacity to

Syphilis

100%

47.1

--

--

diagnose RTIs below the

Chlamydia

100%

--

--

--

visually observed cervicitis
were found to be 60–70

county level of service,
while most people seek health services at the township level (Table 1). In addition, the treatment
of symptoms varies widely. Some women are treated with traditional medicine, while others
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receive antibiotics. Laser therapy is used for more serious cervicitis, which is worrisome given the
possible ill effects of this procedure. Our primary conclusion was that there is an urgent need to
improve the clinical diagnosis of cervicitis and to determine its underlying etiology (for example,
whether it is related to STDs or other RTIs).
Following the literature review, we carried out a field survey in two Yunnan counties,
Chengjiang and Luliang, which are about 100 kilometers from Kunming. Our aims were to establish the prevalence of RTIs and examine health, socio-economic, and behavioral risk factors.
Data were collected using a questionnaire on social and behavioral risk factors; conducting clinical
exams for symptoms; and conducting lab tests for candida, trichomoniasis, bacterial vaginosis,
gonorrhea, and chlamydia. Local field testing was followed by a "gold standard" test in Kunming,
to confirm the presence of infection and assess lab capacity at the local and central levels.
Rates of cervicitis were

Table 2

found to be alarmingly high,
although rates of specific RTIs were

Preliminary Results: Findings from RTI Baseline Survey
in Chengjiang and Luliang (N=2020)

lower (Table 2). In examining
Diseases

possible determinants, preliminary

Cases

Rate (%)

analysis of the data showed the

Normal women

379

18.8

following: most women have ac-

Cervicitis

1176

58.2

cess to tap or well water (water puri-

Candida vaginitis

786

38.9

ty is good in China); the frequency

Trichomonas vaginitis

327

16.2

Bacterial vaginosis*

175

14.7

Gonorrhea

7

0.3

Chlamydia**

90

5.5

of bathing varies greatly (32 percent
of women bathe once a week and
68 percent bathe less than once a
week); the rate of IUD use (45
percent of current contraceptive

*
**

1189 women were tested for bacterial vaginosis.
1643 women were tested for chlamydia.

users) is similar to the national level;
21 percent of the women had had
one abortion, while 8 percent had had more than one. Self-reported symptoms revealed
disturbingly high levels of morbidity (37 percent reported itching, 35 percent reported abnormal
discharge, and 53 percent reported malodorous discharge). Analysis of risk factors is continuing
and the results should be available in mid-1996.
Our qualitative work was not as successful, due primarily to the difficulties of carrying out
anthropological research in a country where social science research has been taboo for more
than 30 years. We did succeed in eliciting some interesting information, however. The women
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surveyed call all RTIs "syphilis," and also have other terms for specific RTIs. Candida, for
example, is referred to as "syphilis" or "lower body itching." If women use the latter term, they
receive traditional herbal medication, which only works for a short time. They use graphic names
for their infections, which are descriptive of the symptoms, including "nasal mucous" for discharge
and "stool smell" for odor. Most women do not believe that RTIs are related to sex. Many believe
that they are the result of poor hygiene and that they can be caused by an imbalance of hot and
cold in the body.

Conclusions
We are working to convince the local health authorities to pay greater attention to RTIs.
We hope that our study will help the Ministry of Health refine its definition of cervicitis and
determine its causes, which is urgent given the high levels of cervicitis and the risk of HIV in
Yunnan. We also hope to develop a risk assessment tool for specific RTIs, which could be used
in Yunnan to help identify women at high risk in order to refer them for further screening before
IUD insertion or abortion. Finally, we are also providing training to local health personnel on RTI
diagnosis and treatment.
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INDIVIDUAL PERCEPTIONS: QUALITATIVE RTI RESEARCH
Huda Zurayk
The Population Council
Cairo, Egypt

The interdisciplinary research on which I will report focused on gynecological and related
reproductive morbidity among women in Giza, a rural area outside of Cairo, Egypt. The study
group was a community sample of 509 women; eligible participants were ever-married, nonpregnant women, aged 14–60. They were primarily non-literate and most were currently married;
most had been younger than 16 years old when they first married, and had had more than three
children.
Household interviews were

Table 1

conducted to collect background information
Percent Prevalence of Gynecological Morbidities

on the women and their reported symptoms
of morbidity. The women were invited to a

Condition

health center for a clinical exam and laboratory tests. It was determined that 51
percent of the women had RTIs, 22 percent
had cervical ectopy, 11 percent had suspicious cervical cell changes, and 56 percent
had genital prolapse (see Table 1). Based
on these findings, it is clear that women's

%

Reproductive tract infections (RTIs)*
· Vaginitis
· Bacterial vaginosis = 22
· Trichomonas = 18
· Candida = 11
· Cervicitis (Chlamydia = 9)
· Pelvic Inflammatory Disease

51
44

Cervical ectopy
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Suspicious cervical cell changes

11

Genital prolapse:
Posterior or anterior vaginal
Posterior and anterior vaginal
Vaginal and uterine

56
27
21
8

Number of women

502

10
2

health problems extend beyond those
related to pregnancy.
Our objective was not only to collect
medical data on the prevalence of
reproductive tract infections (RTIs) and

* Some women have more than one RTI

related gynecological morbidity, but to
compare those findings with women's

perceptions and investigate health-seeking behaviors related to gynecological symptoms. We
found that the majority of women do not use health services when they experience such
symptoms, because they do not consider them to be abnormal or problematic. The only type of
problem a substantial proportion of women perceive as problematic, and as cause for consulting a
physician, is a delay in conception. On the other hand, medical consultation was least likely for
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problems with intercourse.
The women lack awareness of the potentially serious nature of certain RTIs. Socioeconomic and cultural constraints compound the problem of addressing RTIs: for example, when
the study field workers tried to take the women found to suffer from a disease for health care, the
women did not always have time to go; often field workers had to negotiate for permission from
the husband or mother-in-law to do so. Related issues documented by the study include women's
low position of power within the community, poor economic conditions, heavy workload, and low
educational status. Case studies of the women referred for health care were prepared and
published jointly by UNICEF and the Population Council in a book entitled The Silent Endurance.
These qualitative texts complement the quantitative data on prevalence, and forcefully show the
social conditions that constrain the health situation and health-seeking behavior of women. More
research is needed on women's perceptions of their health within the context of their socioeconomic and cultural circumstances.
As a result of these findings, we decided to begin developing a health education packet
that will raise the awareness of women about the symptoms of reproductive morbidity and of the
need for care.
Adepeju Olukoya
Women's Health Association
Lagos, Nigeria

Based on hospital data and the high level of infertility—as much as 50 percent in some
communities—we know that reproductive tract infections (RTIs) are prevalent in Nigeria.
Intrauterine devices (IUDs) are one of the most popular means of contraception, a troubling fact in
the context of Nigeria's resource constraints, serious electricity and water supply problems, and
probable high infection rates.
The objectives of the RTI study we conducted were to:
· define men and women's perceptions of reproductive morbidity and, specifically, their
perceptions of vaginal secretions, sensations, and sores, using a life-cycle approach;
·

describe help-seeking behavior for perceived abnormalities; and

·

define male and female perspectives with regard to the provision of RTI care and family planning services.

The study had two phases, the second of which was truncated due to political problems.
The methodology used in Phase I consisted of in-depth interviews related to women's experience
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through the life cycle, including puberty, the reproductive years, and menopause. During this
phase, we spoke with traditional healers, pregnant women, postpartum women, family planning
users and non-users, herb sellers, and menopausal women.
In studying male and female perceptions of reproductive morbidity, we found that the
range of normal to abnormal was very wide: vaginal itching, "hotness," and "tightness" for
example, are considered normal phenomena at certain times during the female life cycle.
Similarly, menopause is not seen to have a beginning or an end; if a post-menopausal woman has
vaginal bleeding, for example, she would simply think she had not yet completed menopause,
when in fact the bleeding could be a sign of a serious problem. We found that it is socially
acceptable for men to network sexually when their wives are pregnant or postpartum, while
retaining the privilege of returning to their wives for sexual relations. Interestingly, we found that
men refer to RTIs and sexually transmitted diseases (STDs) as infections "caught from women."
We also learned that family planning methods are perceived to be causally associated with
abnormalities in the genital tract.
Most women said that they would talk to traditional healers as the first line of help if they
felt they had a problem. Most of the methods that traditional healers use—herbal preparations
(including their use as pessaries), drinks, and so forth—are either harmful or, at best, do nothing
to heal the women of their illness. We were surprised to learn that the traditional healers
considered foul-smelling or bloody discharge to be abnormal. Most of the women in the study
thought of such discharge as normal at some phase of life.
Our conclusions were as follows:
· Given that it is acceptable for a man to "network" sexually and continue to have sexual
relations with his wife, she and her unborn child are placed at increased risk of RTIs. As
such, there are culturally sanctioned increased risks of infection to mothers and children.
· Widespread misinformation and inappropriate help-seeking behavior affects women
from puberty through menopause. These misperceptions are not limited to women of
poor economic and educational status; educated and economically-privileged women also
believe that certain types of abnormal discharge and other RTI symptoms are normal.
· Most women with RTIs are asymptomatic.
· Current help-seeking behavior may actually increase the incidence of illness.
Nandini Oomman
Johns Hopkins University
School of Hygiene and Public Health
Baltimore, Maryland
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The qualitative and quantitative study on which I will report was entitled "Ethnomedical
models of dhola pani in rural Rajasthani women." Dhola pani, the local term for white discharge,
was chosen as the focus of the study because it was a complaint that women frequently made to
health care providers in this community. An ethnomedical model is a model of the way in which
people in a particular community conceptualize an illness with respect to its causes, symptoms,
pathophysiology, and treatment.
The first phase of the study involved ethnographic research. We began by selecting
women in the community whom we felt would be good informants about the problem of dhola
pani. The objectives of the first phase were to:
· ask women how they conceptualized the problem;
· determine if an ethnomedical model existed;
· determine the appropriate terminology to use to ask women related questions; and
· generate appropriate instruments for further research.
The second phase of the study involved a survey to collect information on demographic
variables as well as on women's menstrual and obstetric histories.
The third phase involved clinical examinations. We used this approach because the facilities to conduct lab tests were not available. The purpose of the clinical phase was to compare
reports that women gave regarding dhola pani with clinical findings related to infection.
Through our research, we found that women complained of other possible reproductive
health problems in addition to discharge. They said that they had equally serious problems with
continuous bleeding, which they called "feet walking," and various types of prolapse, which they
referred to as "body coming out." There were also many different terms used for discharge,
including "body is melting" and "bones melting" for white discharge, and "brown falls" and "maroon
falls" for bloody discharge.
Using the study findings, we constructed a model based on the way women describe their
problems. They believe that economic disadvantage results in worry, anger, lack of food, and too
much work; these problems lead to physiological weakness, which in turn results in discharge.
They believe that sterilization, intrauterine device (IUD) insertion, abortion, problems in childbirth,
eating hot foods, and different sexual intercourse practices are all "opportunistic" factors which
affect them in their already weakened, vulnerable condition, resulting in discharge. The women
also associate several other physical problems with discharge, including backaches, leg aches,

24

sore veins, dizziness and fainting, and panic and anxiety.
As noted above, women perceive the root cause of discharge as an economic one. They
do not view it as a sign of infection and therefore do not seek care. They also believe that the
problem would be solved if they had better nutrition. A few quotes from the surveys illustrate this
thinking: "If there is food in the house, there is no weakness," "Dhola comes from the same place
as menstrual blood, so when a woman is strong, then blood flows properly. When she is weak
and doesn't have her daily food, then dhola falls, her bones melt." It is clear that their
understanding of the problem is very different from the biomedical model.
When women experience discharge, they sometimes seek treatment from traditional
healers. Most often, however, they employ such home remedies as use of water chestnut, which
they feel has high nutritive value. We also learned that many women speak to no one about the
problem of discharge, while some speak with their husbands, mothers-in-law, and friends.

Conclusion
Women report dhola pani as a symptom of a larger problem, but they think of its etiology
very differently than it is conceptualized in the biomedical model. Our clinical work indicates that
reproductive tract infections (RTIs) are present in this community, but women's perceptions of the
problem are such that they do not think that curative or preventative means for dhola pani are
available. Sex and health education will thus be key in helping them to accept the role of health
care and to seek it when they face this problem.
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THE UTILITY OF ALGORITHMS AND RISK SCREENING
Earmporn Thongkrajai
Community Health Development Project
Department of Medicine and Surgical Nursing
Khon Kaen University
Khon Kaen, Thailand

Conventional sexually transmitted diseases (STDs) are a major public health problem:
they represent 20 percent of medical consultations in some developing countries and are among
2

the top five reasons for which medical advice is sought. In sub-Saharan Africa, they are thought
to be responsible for 17 percent of productive life-years lost to disease. For women, in particular,
STDs present a severe threat to health and well being—in addition to pain and discomfort, STDs
may also cause long-term reproductive health problems, such as infertility and chronic pelvic pain.
Sexually acquired infections may also lead to ectopic pregnancy and cervical cancer, which can
lead to death.
The provision of services to asymptomatic women is an essential part of STD programs,
both to prevent complications and sequelae, and to interrupt the transmission of infection.
Without such services, STDs cannot, by definition, be controlled. Even in countries with the best
developed STD prevention and control programs, services tend to concentrate on the treatment of
those who seek care because they have symptoms. Many women, however, will be
asymptomatic, and thus undiagnosed, prior to the development of complications. Others are
either unaware of the significance of symptoms or are reluctant to seek care for fear of
stigmatization.
Maternal and child health and family planning (MCH/FP) programs are in a unique
position to assist in reducing the spread of STDs and human immunodeficiency virus (HIV) (80
percent of women with HIV infection are of reproductive age). Not only do such programs employ
the largest pool of health personnel, but they also have experience dealing with such interventions
as counseling and the provision of contraception, which are closely related to the prevention of
STDs, including HIV. If these programs played a more active role in primary prevention, by
encouraging behavior change, and in secondary prevention, through effective case management,
they would reach many women. In addition, some women obtain health services, either for their
children or for themselves, only through MCH/FP programs.
2

WHO/GPA. Provision of STD Services in Maternal and Child Health and Family Planning Setting, Background
Paper No. 8, June, 1992.
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An essential element in testing the feasibility of integrating STD services into MCH/FP
programs is the choice of a method for diagnosis and case management for asymptomatic
women and those who do not report symptoms. To address this, a study conducted in Thailand
developed an algorithm for diagnosis and management of STDs among women attending family
planning and antenatal clinics under the MCH/FP program in the Chumpae district hospital in
Khon Kaen province. The specific objectives of the study were to determine the prevalence of
STDs and associated risk factors among women attending the clinics, and to validate a risk score
for STD management among women who do not report symptoms.

Study summary
Women presenting to family planning and antenatal clinics in the Chumpae district
hospital during a period of ten weeks were included in the study, along with some additional
women from the Nampong district, which is similar to Chumpae. A total of 793 women were
enrolled. Identical data collection procedures were followed—a physical examination, specimen
collection and testing for STDs, and a screening interview. Data analysis of the pooled cases was
conducted as a preliminary attempt to develop and validate the algorithm.
Focus groups Four focus groups were held among women aged 18–45 from villages
served by the Chumpae district hospital. The objective was to explore and gather information on
women's perceptions and beliefs regarding possible symptoms related to STDs. Of particular
interest were their definitions of and the terms they used for vaginal discharge, itching, malodor,
lower abdominal pain, difficulty with urination, and discomfort or tenderness around the cervix.
Information was collected on their knowledge, attitudes, beliefs, sexual behavior, and preventive
and curative behaviors. This information was then used to prepare the questionnaire for
structured interviews, described below.
Interviews Each woman attending the MCH/FP clinic was interviewed by a health worker
using a structured questionnaire. Information was collected on the following:
·
·
·
·
·

·
·
·

personal characteristics: age, education, occupation, marital status, place of residence
number of induced abortions
previous STD(s)
perceived risk of STD
risk factors for STDs: age at first intercourse, number of sexual partners in the last
year, duration of relationship with current partner, duration of marriage, change of
partner in last three months
husband or partner's age, occupation, education, residence, STD status, length of
time away in past three months
contraceptive use
current symptoms: dysuria, vulvo-vaginal itching, dyspareunia, lower abdominal pain,
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vaginal discharge, genital ulcers, skin rashes
Physical examination Vaginal, cervical, urine, and venous blood specimens were
collected. On-site lab tests were performed for T. vaginalis, C. albicans, bacterial vaginosis, N.
gonorrhea, C. trachomatis, and syphilis. A bimanual pelvic examination was also carried out. All
women were examined for the following:
·
·
·
·
·
·
·
·

skin, sole, and palm rashes
vaginal discharge (type, color, odor)
cervical discharge (after cleaning), and whether mucopus
cervical dysplasia/ectropion (whether contact bleeding), cervicitis
genital ulcers
genital warts
condyloma lata
anal alterations (ulcers, rectorrhea warts)

Health education and treatment All participants received advice and information on
HIV/AIDS, and were offered a supply of condoms at the initial visit. Infected patients were treated
according to the regimen used at government STD clinics.

Results and discussion
Study results indicate that the

Table 1

prevalence of chlamydia is slightly over 3
percent—about half the rate expected based

Prevalence of STDs Among Women Aged
15–39 Years in Pooled Sample (N=793)

on earlier data—while the prevalence of
syphilis and gonorrhea are under 1 percent

STD

Percent

(Table 1). Women whose husbands often
worked away from home and who had not

Positive syphilis serology*

0.6

Gonorrhea

0.1

Chlamydia

3.3

lived with their husbands during the past
three months had significantly higher rates
of chlamydia than women whose husbands
were away less frequently or who had lived
with them in the past three months (Table
2). Women who reported lower abdominal

* RPR and TPHA tests both positive

pain had significantly higher rates of
chlamydia than women who did not report
this problem. No relationship was found between chlamydia infection and reports of dysuria,
vaginal discharge, and vaginal itching. A positive leukocyte esterase dipstick (LED) test, however,
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was found to be associated with the presence of chlamydia. More than twice as many women
tested positive, rather than negative, for the infection.
A logit regression analysis was conducted to determine the association of chlamydia with
each of the four risk factors identified—frequency of the husband working away from home,
husband and wife living together during the previous three months, lower abdominal pain, and a
positive LED test. The only factor that did not remain significantly associated with chlamydia
prevalence was a positive LED test.
Table 2
Proportion of Women in Pooled Sample Infected and Uninfected with Chlamydia by
Selected Characteristics
Total
Infected
%

Characteristic

Uninfected
%
%

N

Age (in years)
15–19
20–24
25–29
30–34
35–39

2.2
4.9
3.1
2.3
2.0

97.8
95.1
96.9
97.7
98.0

100
100
100
100
100

(93)
(245)
(225)
(128)
(102)

Number of abortions
None
One or more

3.3
2.6

96.7
97.4

100
100

(631)
(158)

Frequency of husband working away from home
(past year)
Never away
One to three times
Most of the time

2.9
0.6
6.3*

97.1
99.4
93.7

100
100
100

(391)
(169)
(224)

Husband and wife lived together in past 3 months
Yes
No

2.8
6.5*

97.2
2.8

100
100

(641)
(107)

5.9
2.9

94.1
97.1

100
100

(102)
(687)

3.7
3.3

96.3
96.7

100
100

(27)
(764)

4.0
3.2

96.0
96.8

100
100

(26)
(765)

Self-reported symptoms
Dysuria:
Yes
No
Vaginal discharge:
Yes
No
Vaginal itching:
Yes
No
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Lower abdominal pain:
Yes
No
LED test on urine
High (100 cell/ml)
Moderate (75 cell/ml)
Trace (10-25 cell/ml)
Negative

5.8*
2.3

94.2
97.7

100
100

(224)
(567)

5.6*
----2.5

94.4
----97.5

100
----100

(214)
(11)
(2)
(558)

* Chi-square significant at p < .05
Note: "Number of sexual partners in the past year" and "change of sexual partners in past three months" are not included in table because 99 percent of
women responded "none" and "no change," respectively, to these questions.
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This methodology enabled us to
determine the number of true cases diagnosed

Table 4

by an algorithm based on the four risk factors

Results of the Application of a ScoreDriven Algorithm for the Screening of
Women for Chlamydial Infection (pooled
sample)

(true positives), the number of women treated
based on applying the algorithm (true plus false
positives), its sensitivity (number of cases

Number of infected women
diagnosed by laboratory test

25

Number of true cases diagnosed by
algorithm (true positives)

19

Number of women treated following
application of algorithm (true plus
false positives)

347

Sensitivity (%)

76.0

algorithm are presented in Table 4. Although

Specificity (%)

46.8

the model has a sensitivity of 76 percent, its

Positive predictive value (%)

5.5

detected/total number of infected women), its
specificity (number of negative women/total
number of uninfected women), and its positive
predictive value (the number of true positives
diagnosed by the algorithm/number of women
treated based on applying the algorithm).
The results of the application of the

specificity is less than 50 percent, and its
positive predictive value is under 6 percent. The latter result is particularly important: in order to
achieve 76 percent sensitivity, the proportion of the population over-treated by using this algorithm
is greater than 90 percent. This level of over-treatment raises ethical questions—through
treatment of uninfected individuals—and cost questions—in that it uses scarce resources
unnecessarily. On the basis of these findings, it has been determined that the algorithm cannot
be used for screening women for chlamydia in MCH/FP facilities in Thailand.
Several risk factors were identified that are significantly related to the prevalence of
2

chlamydia. Their combined effect, however, was almost negligible, with R measured through
2

multiple regression analysis at only 0.04. (The R measures the proportion variation in the data
that can be explained by all the risk factors tested in the model. In this case, the model explains
less than 4 percent of the variation in prevalence. In other words, they are unable to account for
96 percent of the variation in prevalence.) It is, therefore, unlikely that they would be sufficient,
along with the other risk factors, to increase the positive predictive value of the algorithm to an
acceptable level. It should be noted that, where the prevalence of STDs is higher than in the
setting studied here, such screening tools may prove to be more useful.

Conclusions
The low level of STD prevalence raises questions regarding the practicality of using an
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algorithm to diagnose STDs among women attending MCH/FP facilities in the Thai context. Even
if the screening tool had a sensitivity and a positive predictive value of 100 percent, it would only
identify four cases out of each 100 attendees, which would not justify the time and effort involved
in employing it. As an alternative, an intervention that integrates STD education, referral, and selfassessment of risk into MCH/FP programs should be investigated. This could be accomplished
through training programs for health promotion officers, who are clinic based, and village health
volunteers, who are based in the community. Such a training program would consist of the
following:
· Training health promotion officers to improve their knowledge about STD/HIV
prevention and their ability to communicate this knowledge, and informing women
who attend clinics on where STD services can be obtained (referral).
·

Training for village health volunteers to improve their knowledge about STD/HIV
prevention and services and ways to communicate this knowledge during home visits
and group meetings, and educating women on how to assess their own risk of
STD/HIV, based on conventional risk factors and those identified in the study.

The intervention would also include the provision of information on STD/HIV prevention
and location of STD services within the information, education, and communication (IEC)
component of the MCH/FP program.

DISCUSSANTS
Huda Zurayk
The Population Council
Cairo, Egypt

When we began the Giza study on which I reported earlier, we were interested in
women's reports related to the presence of reproductive tract infections (RTIs) or symptoms
indicating their presence. We were not only attempting to determine whether or not algorithms
were useful for screening, but also to determine the magnitude of the problem in the community.
The study was conducted in a small community; because of its cost, it could not be replicated on a
larger scale. One of the objectives of this study was to learn the extent to which women's reports
of symptoms, compared to medical exams, could give us an estimate of the prevalence of
gynecological conditions including RTIs.
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Our work involved the use of a

Table 1

number of methods. Seventy-seven
percent of the women reported

Prevalence of Reproductive Tract Infections (RTIs) Using
Various Diagnostic Methods

discharge, but only 13 percent of the
%

women considered it "not their nature,"
that is, suspicious to the women. The

Presence of discharge by clinical examination

83

women reported characteristics of the

Medically diagnosed RTI (lab tests)

51

discharge they were experiencing in

Women's report of discharge
Presence
Suspicious to woman
Suspicious medically

77
13
63

Diagnosis of RTI based on review by physician of:
Interview questionnaire
Clinical exam sheet and questionnaire

61
70

terms of color, odor, consistency, and
accompanying itching. When these
were analyzed, 63 percent of the women
were considered to have medically
suspicious discharge. By comparison,
the examining physicians observed

discharge in 83 percent of women. We also asked an independent team of three physicians to
review the women's reported symptoms from the interview alone, and to review these reports in
combination with the medical exam sheets. In the former case, they determined that 61 percent
of the women had RTIs; in the latter case, the figure rose to 70 percent. In both cases, physicians
overestimated the problem. However, as an estimate of magnitude of the problem of RTIs, all
methods pointed to its gravity, except women's perceptions of the seriousness of the discharge.
When we tried to examine the agreement for each woman's report of discharge with the physician
observation, we found poor correlation between the woman's report and medical diagnosis.
Women's reports of discharge were thus shown not to be predictive of the occurrence of RTI.
We then tried to determine whether these results might relate to the fact that the women
did not know what to look for in terms of symptoms and/or to their behavior prior to having clinical
exams. We had asked them to refrain from washing prior to going to the clinic so that if they had
reported discharge the physician would be able to observe it. Despite our request, however,
many probably did wash before the exam, which is common practice.
Do we give up asking about women's perceptions of their symptoms since we know they
are not predictive medically? Can we, through surveys, get some idea of the conditions women
have? It is important—from the point of view of learning about women's experiences— to
determine whether women have discharge or other symptoms, and what they consider to be
serious. These reports can be used as a community assessment of the magnitude of the problem
and are indicative of the perceptions of women and their health-seeking behavior related to
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symptoms of RTIs.

Inne Susanti
University of Udayana
School of Medicine, Pathology Department
Denpasar, Bali, Indonesia

I plan to discuss the utility of algorithms and risk screening based on a study of
reproductive tract infections (RTIs) in Bali. The objective of the study, which was cross-sectional
in design, was to determine the prevalence and range of RTIs among women presenting at clinics
for menstrual regulation and to develop a simple and inexpensive approach for RTI detection.
The information we collected was similar to that described by Dr. Thongkrajai, and the same
questions were asked about discharge and other symptoms. We also conducted speculum
exams and laboratory tests, and took vaginal specimens (for a potassium hydroxide (KOH) odor
test, pH test, wet mount culture, and gram stain), blood samples (for syphilis and HIV tests), and
cervical samples (for chlamydia testing, Pap smear, and swab test).
We tried to determine risk levels from the demographic information collected using the
questionnaires and compared these with the clinical data, but they did not correspond. We found
that the algorithms were not predictive. As such, it is essential that more thought and discussion
be devoted to the use of algorithms for RTI management.

Discussion
Christopher Elias: We should move away from the term "algorithm" because the word
means different things to different people. We need to discuss two different issues: case
management, on the one hand, and case finding, on the other. There are different ways to
conduct case finding. The best is to use expensive diagnostic tests in a rationed manner,
perhaps with high-risk populations: this has been done in the U.S. and Australia by testing
adolescents, because we know they are at greater risk of having infections and that the
consequences are particularly serious for this group, indicating that it may be wisest to focus extremely scarce resources in this way. We need to determine if screening by other means, such as
risk scoring, has any utility. At the same time, and most importantly, we need to invest in better
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and cheaper diagnostic technology.
Beverly Winikoff: We have to examine the fact that one of every two women who are
determined by risk screening to have an RTI does not have an infection. What are the
consequences for that woman of being labeled in this way? What are the risks to people of being
labeled positive or negatively falsely, and to which of these risk are we most averse? What is the
response to a positive diagnosis? In resource-constrained environments, are people being
treated for infections they do not have? These and other important questions must be explored.
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BUILDING THE COALITIONS NEEDED TO ADDRESS RTIS:
SERVICE PROVIDERS, POLICYMAKERS, COMMUNITIES
Nguyen Kim Cuc
Vietnam Women's Union
Hanoi, Vietnam

Vaginal and cervical problems are common in Vietnam and have serious implications for
the health of women and their families, especially through their potential impact on fertility. The
prevalence of reproductive tract infections (RTIs) among women of reproductive age in Vietnam is
approximately 50 percent, and as high as 80 percent in some provinces. Vaginitis and cervical
infection are extremely common, affecting about 90 percent of women of reproductive age.
In the past, Vietnamese women, and particularly those in rural areas, used traditional
medicine for RTIs and rarely sought help from the formal health care system. In recent years,
however, the latter system has been strengthened and many more women now utilize its services.
Unfortunately, many women in remote rural areas lack access to the services that urban women
enjoy. As a result, the Vietnam Women's Union has made women's health care a priority. We
believe that "Health is wealth," and have organized medical check-ups and consultations for
women, as well as family planning education campaigns. The Union, which works in collaboration
with the Ministry of Health and a number of provincial health services, has also conducted surveys
to determine the causes of RTIs and, based on these findings, is developing intervention
strategies.

Survey findings reveal the following:
·

poor knowledge of hygiene in general, and of menstrual and sexual hygiene in
particular;

·

lack of safe water and poor sanitation; and

·

poor medical services, including unsafe intrauterine device (IUD) insertion, abortion,
and menstrual regulation.

Based on the incidence of RTIs and their root causes, some of which are mentioned
above, the Vietnam Women's Union realized that the problem could not be addressed effectively
unless a strong coalition was built among a wide range of institutions, including the Ministry of
Health, the Ministry of Labor—which is responsible for the water supply program— and the War
Invalid and Social Affairs and Youth Union, which is responsible for education on sanitation.
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Through this coalition, which began work in 1992, we hope to succeed in our efforts to reduce the
incidence of RTIs.
Inne Susanti
University of Udayana
School of Medicine, Pathology Department
Denpasar, Bali, Indonesia

About 70 percent of the women surveyed in the study I described earlier had experienced vaginal discharge; most of the women had also experienced itching and most did not
realize that these could be symptoms of a problem. Many women think that vaginal discharge is
caused by stress, certain foods, or poor hygiene. In addition, some women use oral and vaginal
preparations that affect reproductive tract infections (RTIs), including vaginal tightening agents for
sexual intercourse. Women reported that they were unsatisfied with the information they received
from health care providers when they did inquire about their symptoms; indeed, many indicated
that doctors and other providers told them that discharge was no cause for concern.
We learned from women and from discussions with doctors and midwives that information about RTIs is scarce. Health care providers reported that the reason they did not conduct
clinical examinations to test for RTIs is that the women they treat are modest and do not want to
be examined by male doctors. In addition, doctors said they were hesitant to discuss the possibility that a woman might have a sexually transmitted infection because they did not want to
disrupt her family life. In most cases, therefore, no vaginal specimens are taken. Almost all of the
midwives and doctors interviewed reported that they make a diagnosis on the basis of the symptoms that a woman describes. The most common diagnosis made on this basis is candida.
The problem of RTIs has never been so urgent. As such, it is more important than ever
that we overcome the obstacles to dealing with the problem, collaborate, form coalitions, and disseminate information about the prevention and treatment of RTIs. Possible steps include
providing more training and information to health care providers, increasing program and policy
focus in this area, setting up mobile clinics for RTI screening, and establishing interdisciplinary
coalitions to address and research RTIs.

Nicola Jones
The Ford Foundation
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Manila, Philippines

There are three questions we might ask regarding coalition building around reproductive
tract infections (RTIs):
1. Why do we need coalitions?
2. What are the obstacles to coalition building?
3. How do we overcome these obstacles?
We need coalitions for a variety of important reasons. Participants in a recent HIV/AIDS
and Development Awareness Seminar Workshop in the Philippines, for example, suggested that
these include: opportunities to improve skills, coordination and support, facilitating referrals,
maximizing existing resources, and a wide range of other factors.

Why do we need coalitions?
As we have discussed during this meeting, RTIs are rarely perceived to be a problem—
even by those who suffer from them. Unlike AIDS, they are a "silent emergency." Coalitions can
help place RTIs higher on the public health agenda. I believe that a multi-sectoral approach is essential in this regard: RTIs are not simply a medical problem—they also have social, cultural,
moral, economic, and political implications.
My experience in supporting coalitions suggests that while it is helpful to have as wide a
membership as possible, numbers do not guarantee success. For RTIs to gain public attention,
members must be driven by their own interest in, commitment to, and preferably passion for the
issue—and not commandeered as representatives of a particular agency. They must also have
access to accurate, local information. Research coalitions, in the form of participatory and interdisciplinary research programs, have a crucial role to play in identifying the issues and mobilizing
action.
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Donors—and particularly private
Obstacles to Coalition Building

donors—are in a very privileged position in
the area of coalition building, and have much

·
·

to gain from them. Coalitions maximize the
use of limited resources, generate energy,

·

and achieve an impact that would not be

·
·
·

possible with individual partners.

What are the obstacles to coalition
·
·

building?
For coalitions to work effectively,
members must understand and respect the
contributions of those who represent different

·

Status and power of physicians and lawyers
Misunderstandings between medical, biomedical, and social scientists
Uneasy relationship between NGOs and
government agencies
Few NGOs are interested in health
Many feminist NGOs are in capital cities
Provincial grassroots women are often not
organized and not linked with urban feminist
NGOs
Policymakers' negative attitudes
Decentralization of responsibility for many
services to local governments, with
commensurate central government loss of
implementing power
Religion and cultural values

organizations or perspectives and share
common principles and goals. There are several factors that work against open and equal
partnerships. Non-governmental organizations (NGOs), for example, are often wary of working
with governments. Physicians and lawyers rarely feel challenged by others, particularly by poor
women. Feminist organizations from capital cities do not have close ties with grassroots women's
organizations, which are rarely well organized. Many policymakers are uncomfortable with issues
related to sexuality and reproductive health. Conservative religious views often conflict with
women-centered approaches to these issues.

How do we overcome these obstacles?
In order to overcome these and other obstacles, the Ford Foundation in the Philippines is
developing partnerships around the issues of sexual and reproductive health. We encourage
interdisciplinary and multi-sectoral programs to research and address RTIs, in order to bring activists from a wide variety of backgrounds together to work effectively on the issues surrounding
RTIs. We support national and regional working groups, the establishment of an interagency
advisory committee to the government's Commission on Population to help develop an agenda
that is sensitive to reproductive health concerns, and the development of an interdisciplinary
diploma and a Masters level health/social science program on gender, sexuality, and reproductive
health to train new professionals in the field. We are still in our first phase of combat against
RTIs, but we recognize that encouraging communication and interaction among the full range of
partners will be essential to the development of a successful national RTI prevention and
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treatment program.
In order to develop appropriate responses to RTIs, we also need to involve women and
men in research and action programs. By encouraging active partnerships among communities
and NGOs, universities, modern and traditional practitioners, and government agencies, we
should ensure that the expanding knowledge base is systematically linked to policy and program
development.
An often neglected factor in building and sustaining coalitions is having fun. During the
last afternoon of a recent conference, participants celebrated with parlor games, dancing, prayers,
and community singing. This kind of social interaction is crucial to bringing and keeping people
together to work toward a common cause.
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IMPACT ASSESSMENT: WHAT CRITERIA DO WE USE TO DEMONSTRATE
THE IMPORTANCE OF RTIS TO POLICYMAKERS?
Ana Langer
The Population Council
Mexico City, Mexico

Currently, there is agreement among international agencies on the importance of
addressing sexually transmitted diseases (STDs) in the developing world and on the need to
integrate STD management with other reproductive health services. Theoretically, merging
vertical programs and services—such as maternal and child health (MCH), family planning, and
STD services—should have a synergistic, positive effect on women's health. In spite of this
increasing consensus, however, strong skepticism arises among public health policymakers,
program managers, health care providers, and donors when it comes to investing resources in
this area. The following questions arise, which I plan to address in turn. Is it really necessary to
address STDs? Are STD control programs cost-effective? Can the impact of STD control
activities be measured? Is it feasible to implement all the services necessary to ensure that an
STD control program is effective?

Is it really necessary to address STDs?
It is not uncommon to hear that STDs do not deserve the attention that international
agencies are encouraging. Two main arguments, which are not based on true and objective
information, are usually made to support this view.
STD prevalence is low among the general population Unfortunately, data on STD
prevalence among the general population is very scarce. Only approximate figures can be
obtained, based on women attending general, prenatal, or family planning clinics (Brunham and
Embree, 1992; Donoso, et al., 1984; Faundes and Tanaka, 1992; Alvarez, et al., 1992; Weström
and Mardh, 1984). These studies have found rather high prevalence rates for chlamydia,
trichomonas, and, in some contexts, gonorrhea. There are, however, almost no population-based
studies or studies of women who do not use these services. This information is urgently needed
to assess the public health importance of the problem and to develop control and treatment
strategies adapted to each context, since the STD epidemiology varies from country to country.
STDs are not fatal There is sufficient evidence of the devastating effects of reproductive
tract infections (RTIs) and STDs on women's and infants' health (Weström, 1980; Weström, et al.,
1981; Franco, 1991; Reeves, et al., 1989; Wasserheit, 1990). Pelvic inflammatory disease (PID),
infertility, ectopic pregnancy, cervical cancer, increased risk of acquiring HIV/AIDS, fetal wastage,
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low birthweight, and neonatal blindness are among these effects, and there are others.
Dissemination of information about the complications of these preventable and treatable diseases
should be more aggressive. Evaluating health care providers' awareness of the importance of
STDs and their consequences should also be made a priority.

Are STD control programs cost-effective?
Data on the economic burden of STDs in the developing world, as well as the resources
available and needed for their prevention and control, are very scarce. Most of the few existing
studies are simulations. The World Bank (1993) has suggested a strategy for measuring the
cost-effectiveness of health interventions, through which different interventions are compared in
terms of the cost of achieving one additional year of healthy life. Outcomes are measured using
disability-adjusted life-years (DALYs), which are also used to estimate the burden of disease. The
unit cost of an additional DALY is the measure of an intervention's cost-effectiveness; the lower
the number, the greater the value for money offered by the intervention.
Among communicable, maternal, and perinatal illnesses, the World Bank ranks STDs,
excluding AIDS, third in terms of women's disease burden. In the list of priority health
interventions, STDs rank second, following pregnancy-related illnesses, and are categorized as
diseases that can, to a large extent, be controlled using cost-effective interventions (less than
$100 per DALY saved). The importance of STDs in terms of their contribution to the disease
burden and the availability of effective and inexpensive interventions led the World Bank to
recommend STD-related interventions as a component of a minimum package of care.
The limitations of the World Bank strategy include the fact that cost-effectiveness
estimates were not calculated separately for each STD and that obstacles related to work in the
field were not considered. For instance, screening for chlamydia may be less cost-effective than
for syphilis, and the ratio varies according to local prevalence. In addition, availability of drugs,
equipment, laboratory facilities, and so forth, would also modify the cost-effectiveness in different
contexts.
Only a small proportion of the thousands of STD-related interventions were analyzed
using the methodology described above. Among them, interventions for preventing congenital
syphilis have a favorable cost-effectiveness ratio. Because syphilis treatment is simple and
affordable, screening and treatment during the prenatal period has been widely recommended.
Other studies have found that eye prophylaxis at birth to prevent gonococcal ophthalmia
neonatorum is much less expensive than treating the cases themselves (Laga, et al., 1989), even
at maternal gonorrhea prevalence rates of less than 1 percent. These activities have a favorable
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cost-effectiveness ratio in both developed and developing countries (Stray-Pedersen, 1983).
Effective interventions exist for other STDs, but the lack of simple, appropriate, rapid, and
inexpensive diagnostics for use in the field render these measures much more difficult and
expensive to implement. Consequently, when resources are limited, such interventions should be
targeted specifically to high-prevalence groups in order to be cost-effective. Estimates suggest
that if the prevalence of an STD is greater than 10 percent, treating everyone in the risk group
may be more cost-effective than screening, especially when laboratory facilities are not available
or are insufficient (Piot and Rowley, 1992).
Using a different methodology—cost per case averted—Shulz and colleagues (1992)
compared the seriousness of the problems conventional STDs cause to infants to that of the
infectious diseases currently addressed by international donor agencies (tetanus, polio, measles,
and pertussis). The authors concluded that the problems caused by STDs are at least as serious
as those caused by immunizable diseases, and the interventions to deal with them seem to be
more cost-effective. Indeed, if benefits to women were included, this would improve the
cost-effectiveness ratio of the interventions even further. This hypothesis, and the World Bank
approach described above, need to be field-tested to increase the likelihood that they will
influence decisionmaking.
Piot and Rowley (1992) contributed to highlighting the economic burden of STDs by
reviewing the information available on the direct and indirect costs of the management of STDs
and their sequelae in developing countries. The authors calculated the direct costs of different
screening procedures and concluded that while clinical diagnosis is the least expensive and most
rapid, it is also the least sensitive and specific. They also pointed out that no data on the costs of
managing the complications and sequelae of STDs are available; however, these costs would
certainly be higher than those of controlling the infections. Over and Piot (1991) estimated the
indirect costs of STDs and the benefits of preventing them (using discounted healthy life-years) in
an urban area in Africa with high STD prevalence. According to their calculations, preventing
STDs results in considerable improvements in health. Their indirect cost calculations do not,
however, encompass the impact of STDs on infant morbidity and mortality nor the social and
economic consequences of STD-related morbidity or mortality. Finally, Piot and Rowley (1992)
synthesized the scarce information available about the effectiveness and costs of STD
interventions. They stressed that each case of STD prevented will also prevent additional cases.
It is not, therefore, sufficient to compare the benefits of preventing a single case to the cost of the
activities necessary to do so; the benefits to individuals other than those immediately affected
must also be considered. Analyses of the cost-effectiveness of behavioral interventions for the
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prevention of STDs have not been carried out. Condom promotion activities, and especially social
marketing as opposed to free distribution, seem, however, to be successful.
Experts in health economics generally agree on the need to generate more empirical
evidence about the economic impact of STDs. This information is essential to combatting existing
skepticism. Gross cost-effectiveness estimates may not be enough to convince program
managers, public health decisionmakers, and providers that the interventions are worthwhile,
given competing priorities for resources and the logistical difficulties associated with work in this
area. While an efficacy study may show that an intervention can work, an effectiveness
evaluation showing that it works outside of the research milieu and an efficiency study showing
that it is worthwhile and feasible are essential prior to widespread introduction of the intervention
(Ronald and Aral, 1992).

Can the impact of STD control activities be measured?
The main goal of any intervention is to ameliorate the health problem it intends to
address. To demonstrate impact, and before an intervention can be considered for widespread
implementation, a well-designed and methodologically sound evaluation is required. The validity
of the scientific evidence for an intervention can be considered proven when it has shown positive
effects following a prospective, randomized, controlled, and community-based study. This is a
very high standard, extremely difficult to achieve (Ronald and Aral, 1992). Quasi-experimental
designs are an acceptable alternative when comparability among experimental and control sites is
adequate and all relevant variables that need to be controlled for in the analysis are measured;
both conditions are necessary to ensure that such studies have sound internal validity. Scientific
evidence of impact can be categorized as tentative when it comes from uncontrolled,
non-randomized, and often retrospective—or "before and after"—studies. Most evaluations of
STD interventions fall into this category. The positive effects of an intervention can only be
considered as assumed when there is no scientific evidence, but experts in the field think of it as
worthwhile (Ronald and Aral, 1992).
In addition to appropriate research design, demonstrating impact requires accurate
identification of the outcomes to be measured. The development of a careful conceptual
framework based on current scientific knowledge during the preparation phase of an evaluation
usually helps in this regard. Two types of impact outcomes—intermediate and final—can be
measured. The type chosen will depend on the nature of the intervention being evaluated. The
following example will help clarify this concept. The effects of an intervention consisting of
lectures and radio campaigns to promote the use of condoms, for instance, was estimated by
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measuring changes in the awareness of the condom as a method of AIDS and STD prevention
(intermediate outcome) and by actual changes in overall condom use as a prophylactic measure
(final outcome) (Vernon, et al., 1990). Impact outcomes, whether intermediate or final, must be
consistent with the goals of the intervention under evaluation. The impact of an intervention
consisting of screening, diagnosing, and treating gonococcal infection during pregnancy, for
example, would be based on changes in three different outcomes: the incidence of prematurity,
neonatal ophthalmia, and postpartum endometritis.
There are also both impact and process outcomes. For an intervention consisting of the
establishment of STD control services in a family planning clinic, the impact outcomes could be
the prevalence of certain infectious agents among clinic users or the frequency of PID after
intrauterine device (IUD) insertion. Both should be lower after the intervention is established, or
lower than among users of a similar clinic. If the resources needed to complete a prevalence
study are not available, or if patient follow-up is too difficult, process outcomes, such as the
inclusion of information, education, and communication (IEC) about STDs in the clinic's routine
practice or the number of lab tests performed, could also be used to demonstrate changes
attributable to the intervention.
After identifying the outcomes that will allow the effects of an intervention to be
demonstrated, researchers must be sure they have all the elements they need to measure these
effects correctly. They must also develop adequate instruments to collect data and train people to
do so. Attention to these issues is crucial if valid results are to be obtained.

Is it feasible to implement all the services necessary to ensure that an STD control
program is effective?
Finally, feasibility also generates skepticism, and the list of requirements for establishing a
comprehensive STD control program makes this understandable. What must STD programs do
in order to be effective? (Population Reports, 1993)
·

Develop overall strategies based on health care resources and disease prevalence
patterns

·

Develop effective services in primary health clinics

·

Train and equip STD service providers to diagnose and treat patients in one visit

·

Ensure a reliable supply of condoms and drugs to treat STDs

·

Make good STD counseling a high priority
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·

Strengthen STD training in medical, nursing, midwifery, and other health professional
schools

·

Provide in-service training for primary health care providers

·

Involve private practitioners—pharmacists, private doctors, midwives, and so forth

·

Conduct mass media campaigns and in-clinic programs to encourage people to
recognize STDs, seek treatment, and use condoms

·

Conduct surveillance to identify the most prevalent STDs and drug resistance to STDs

·

Set up syphilis screening programs in antenatal clinics

·

Set up special programs for high-risk populations

·

Make sure that the sexual partners of STD patients are treated

·

Combine STD and AIDS programs

Women have a right to obtain the care they need for their health problems, and
professionals, researchers, and activists working in the women's health field have a duty to help
meet those needs. Skepticism is sometimes authentic, but it can also be an expression of
awareness of the difficulties and severe constraints we face in the developing world. Research on
STDs has not yet provided enough information to overcome the skepticism; given the significance
of the problem and the magnitude of the obstacles to overcoming it, investment in such research
is warranted. Each component of an STD program requires epidemiologic, health system, social,
and economic research before it can be implemented with confidence. Demonstration projects to
evaluate comprehensive programs involving most of the components listed above are also
necessary.
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How do those of us working primarily in research convince those who are skeptical to pay
more attention and allocate more funds to the prevention and treatment of reproductive tract
infections (RTIs)? Who are the skeptics? They are donors, politicians, and health and family
planning program managers; these are key strategic groups, although there are skeptics in other
groups as well—including service providers, some advocacy groups, and some researchers
themselves, who all demand different levels of proof that RTIs are a serious problem with costeffective solutions.

Donors
Donors ask, "What is an RTI?" and "Why should we pay attention to RTIs when there are
women dying in childbirth, or when population growth is undermining development?" It is our job
to raise their awareness of the consequences of RTIs; link RTI interventions to their priority
programs, including Safe Motherhood and HIV programs; look for specific opportunities to
improve service delivery related to RTIs, for example including RTIs in a project to upgrade
laboratories or develop training curricula; and collaborate with Women in Development programs
that are already working to integrate gender issues into other program areas.

Politicians
Politicians say, "RTIs cannot happen in my country—we do not have these kinds of
problems," "Our religion prohibits prostitution so we do not have RTIs/STDs," and "Those
international statistics you cite are not relevant here." In order to convince politicians to pay
attention and channel scarce resources to RTI prevention and treatment, we need to:
•

be proactive, by providing them with relevant information from the local context;

•

acknowledge limits of global statistics, but stress global commitments to reproductive
health;
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•

acknowledge and explain the links between RTIs and behavior, and explain that not all
RTIs are sexually transmitted; and

•

accentuate the positive, by giving politicians the good news about successful pilot
projects.

Family planning managers
Family planning managers say, "My task is to bring down the birth rate—women's health
is another department's responsibility." In order to convince them of the importance of RTIs to
their own work, we need to provide them with evidence from studies that reveal that linking RTI
services with family planning programs has no negative effect on contraceptive service provision.
We need cost studies comparing stand-alone family planning services with various levels of
integrated services. We should also emphasize the influence that RTIs have on safe delivery and
use—and continuation of use—of contraceptives.

Health program managers
Health program managers say, "We are already doing this kind of work" or conversely
"We cannot afford to do this kind of work." To meet these arguments, we must do the following:
•

provide them with evidence of the costs and limitations of existing programs, such as
single-purpose STD clinics;

•

help them to improve the RTI prevention and treatment services that are in place; and

•

again, provide them with good news related to pilot projects.

In order to convince the skeptics to focus on RTIs, we need to provide them with
information on the consequences of underdiagnosed and untreated RTIs, and illustrate the
possibilities for integrating RTI interventions with existing programs, tailoring our approach
strategically to the range of skeptics who make up our audience.
Joan Kaufman
Abt Associates, Inc.
Cambridge, Massachusetts

I would like to make a few comments about ways to convince policymakers to pay
attention to reproductive tract infections (RTIs). RTIs have been a problem for a very long time.
There are early studies from India that suggest they were identified as a problem 10–15 years
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ago. A variety of studies, however, suggest that in many settings provider attitudes have impeded
appropriate management of RTIs. Providers often consider vaginal discharge to be normal, and
have not paid attention to abnormal discharge. RTIs have only gained the attention of
policymakers because of the new focus on sexually transmitted diseases (STDs), which has
stemmed from the AIDS epidemic. However, much of the attention has been focused on
symptomatic STDs in high-risk populations. Little attention has been paid to RTIs in the general
population of women; RTIs are the neglected "half-sister" of STDs in men.
In order to change this situation, we must try to provide information on the consequences
of untreated RTIs in ways that matter to policymakers. Unfortunately, some of the early work on
RTIs was faulty in terms of its methodology and did not help in this regard. In my opinion, we
need to document and convey the fact that RTIs cause significant morbidity if not diagnosed and
treated early. This is difficult, however, because many women with RTIs do not seek care for
related problems.
The obvious major consequence of RTIs—infertility—can result in social stigma and other
negative social consequences. In Africa, infertile women are frequently abandoned by their
husbands and then migrate to cities; they may resort to prostitution and, as a result, contribute to
urban health problems. Placing infertility in a larger social context, and documenting its costs,
may be of use in drawing policymakers' attention to the problem.
The adverse birth outcomes and impact on offspring that may result from RTIs, including
pregnancy loss, premature births, and low birthweight infants, should also be pointed out to
policymakers. These problems could be prevented, in part, through diagnosis and treatment of
infection during antenatal care provision.
Underdiagnosed RTIs also play a role in human immunodeficiency virus (HIV)
transmission. In addition, the incidence of human papilloma virus (HPV) is related to cervical
cancer rates. These facts should also be conveyed to policymakers more effectively to
underscore the importance of early intervention.
We also need to do a better job of documenting the indirect effects of morbidity related to
RTIs, such as the effect of pelvic pain and other symptoms which negatively affect women's ability
to work. This type of economic analysis is difficult, but can be very convincing to policymakers.
The main task ahead is to document, to whatever degree we can, the impact of RTIs on
women in terms of measurable and self-perceived morbidity. If we succeed in doing so,
policymakers may be convinced to allocate more funding to prevention, early screening, and
treatment.
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LESSONS LEARNED FROM RESEARCH ON RTIS:
SUMMARIZING THE OBSTACLES ENCOUNTERED
Valerie Hull
The Population Council
Jakarta, Indonesia

This presentation discusses the main obstacles related to research, dissemination,
programming, and policy change in the field of reproductive tract infections (RTIs), as well as
possible priorities for our work and ways of overcoming the obstacles we face.

General obstacles
A range of general obstacles underlie all work related to RTI research, policy, and
programming. There is an overall lack of awareness of the problem and a resistance to
acknowledging and learning more about it. Misperceptions and moralistic denial are found at the
individual, community, program, and political levels. Yesterday, for example, we heard that the
Chinese government had claimed to have eradicated sexually transmitted diseases (STDs) in
China; research in sensitive areas can be interpreted as defying both moral order and legitimate
authority. Women's position in society represents an additional, overriding obstacle, and relates
primarily to their limited negotiating power in all spheres—from sexual relations to client-provider
interactions to the policymaking arena. Poor quality of care also underlies the more specific
obstacles we face: poor provider attitudes, training, management, and systems are formidable
obstacles to reform. Resource constraints and allocation limit the quantity and quality of services;
in some areas, resources are simply not available, and in others, health in general, and women's
health in particular, receive a disproportionately low share of available funds. The general lack of
resources, particularly among women, is also an obstacle because as we have heard, poverty
underlies many of the causes of RTIs.

Developing research
Obstacles related to developing research can be divided into several categories. Set-ting
relevant local priorities is critical, but is often problematic due to a lack of dialogue with or direct
input from community members and a lack of alliances between researchers and service
providers. We have heard a great deal about the importance of getting feedback from and involving family planning and health service providers and professional associations in research so
that they will feel a sense of ownership. Despite our efforts, there is also lack of dialogue between
researchers and policymakers and between local and international research communities.
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The lack of an international
Possible local priorities

coordinating agency hinders our efforts to
set global priorities, although the World
Health Organization (WHO) STD
Diagnostics Initiative and Human
Reproduction Programme (HRP) can play
this role to some extent. The lack of local
research coordination is problematic to all
research, not only research that pertains
to RTIs. Avoiding duplication and
maximizing research efforts is rare, and

.
.
.
.
.
.

secondary research
epidemiological studies
qualitative research
interventions
other Operations Research
other "special purpose"
. antibiotic resistance
. antibiotic prophylaxis for IUDs
. RTI-relevant social and health research
. sexuality
. gender relations
. ethnomedicine
. health service utilization

sometimes reaches appalling levels,
wasting the limited resources we have
available. Unfortunately, overcoming this obstacle is probably a pipe dream; most researchers do
not want to be "coordinated." In many settings, the capacity of researchers is limited, both in
terms of their general background and their training in specific research techniques.
There are numerous examples of
Possible global priorities

possible local and global priorities and
research populations (see boxes), which
demonstrates how difficult it can be to
choose from among them. We are

.
.
.
.

management guidelines
microbicides and female-controlled methods
inexpensive diagnostics
vaccine research

presented with many potentially valuable
research ideas, but decisions among
them must be made.

Conducting research
The capacity of researchers is also relevant to conducting research. We are calling, for
example, for more qualitative research, and in many countries there is a strong cadre of trained
survey researchers now trying to come to grips with these new approaches. It takes some extra
training and reorientation to achieve rigorous qualitative research. Without this rigor, "qualitative
research" is really journalism, and maybe not even good journalism. More women need to be
involved in research and more researchers with the capacity to establish rapport with female
participants must be involved in related efforts. Weak laboratory support facilities are an obstacle
to conducting research in many settings. Respondent sensitivity is also said to be an obstacle by
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health department officials, interviewers, or university-educated local researchers, but does not
always prove to be a problem. Often, when you gather women in a room in an atmosphere that is
conducive to discussing these issues, they have a great deal to say. As such, we are faced with
"gatekeeper reluctance"; that is, it is often the educated elite who are more sensitive than the
respondents. Finally, there are the ethical issues. What is the effect on informants of gathering
information on these issues? What are the ethics of research that does not have an intervention
component?

Interpreting research results
The critical ability of researchers influences their capacity to interpret research results. So
often we see research reports that are primarily descriptive, rather than analytical or actionoriented. This analytical capacity must be developed. Lack of familiarity with qualitative research,
and especially the analysis of qualitative research, comes up again here. Even if researchers are
able to conduct focus group discussions, for example, rigorous analysis of the results is often a
problem. Finally, there are inherent problems of measurement in the area of RTI research,
including the whole area of quality control of diagnostics and the proper conduct of impact studies,
which can be difficult in any field.

Disseminating research results
The writing skills of researchers is an obstacle that hinders the effective dissemination of
research results. Researchers often do not present results in a way that is tailored to particular
audiences, especially policymakers. They often do not establish links with the media or write for
popular publications. Women's magazines in Indonesia, for example, are crying out for articles on
women's health. If researchers were able to provide locally relevant, well- written reports, the
impact of research results would be enhanced. The lack of a reading culture, however, applies in
some settings, including Indonesia. Making reports readable and interesting, and presenting
results through audiovisual means may help combat this obstacle. One implication of a lack of
research coordination that is also problematic is that research reports become part of the
(sometimes permanently) 'fugitive literature.' Finally, there is the moral climate or censorship of
research results, which operates on two levels. First, there is a certain degree of self-censorship
among academics. In Indonesia, for example, researchers avoid sensitive research topics, or do
not report findings that are critical of government programs. Second, there can be outright
censorship by authorities of critical reports.
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Developing and proposing interventions
I have divided interventions into six areas: education, preventive efforts, detection,
treatment, technical/biomedical, and programmatic.
The needs for education are enormous. We have only limited knowledge of local terms
and perceptions related to RTIs, which presents an obstacle to developing effective interventions.
There is also a lack of tested educational approaches, in terms of both message content and
appropriate media. Lessons have been learned from other health promotion efforts and, perhaps,
from approaches that are being tested in the HIV field, but we will nonetheless need to test
approaches that are specific to RTIs. Due to a lack of basic sex and reproductive health
education, women lack knowledge of their bodies. Messages related to RTIs may need to begin
at a very basic level. Developing appropriate messages for client self-assessment of risk, a
subject we discussed earlier, is also an obstacle insofar as, again, there is much we do not know
about message content and delivery.
Obstacles to preventive efforts other than education relate to the pervasive bias against
condoms and barrier methods, both by programs and the population, that prevails in many
developing countries.
There are various obstacles to detection, or diagnosis, including a lack of standardized
terminology and criteria. For example, almost every study that we have reviewed here uses a
different list of RTIs. There is also a discouraging lack of correspondence between clinical and
laboratory findings and intrinsic limits to client self-diagnosis. There are difficult issues
surrounding the management of asymptomatic cases, which relate in large part to the problems
inherent in the development and use of appropriate, sensitive, and reliable behavioral risk
screening methods. The limitations of diagnostics technology come up again and again. There is
an additional aspect to this problem, which has not come up prominently in this meeting, but
which has arisen in our research: there is a certain pride and independence among clinicians, an
attitude that they do not need to rely on technology, and that (true or not) they have become so
experienced at recognizing signs and symptoms through clinical examination that it might be a
retrograde step to become dependent on lab technology when the technology itself is so limited.
Provider training, quality of care, and laboratory support present additional obstacles to effective
diagnosis, as does strict quality control, which applies to all aspects of diagnosis.
Obstacles to RTI treatment include the relative effectiveness of targeting core transmitter
groups versus mass interventions, involving issues of stigmatizing the core group versus the cost-

54

effectiveness of this approach. Antibiotic abuse and resistance are factors in many of the
countries in which we work, as is the lack of a reliable drug supply for poorer segments of the
population. Providers also tend to resist partner notification and treatment; they are reluctant to
get involved and feel that they are not trained in what needs to be done or in the necessary
counseling approaches. Training providers in counseling skills is extremely important. Lack of
confidentiality, which inhibits individuals from seeking treatment, is a problem in many developing
country settings. In Indonesia, for example, there is free HIV testing at a main teaching hospital,
but most people do not want to attend as they feel that everyone will know if they test positively for
the virus.
In the technical/biomedical area there seems to be a lack of consensus on key issues,
including risk screening; antibiotic prophylaxis for intrauterine device (IUD) insertion; and the role
of hygiene and its relationship to RTIs. The development of low-cost diagnostics is also a key
technical/ biomedical concern.
Finally, there are the programmatic obstacles. Programs are often set up vertically, and
there is a lack of coordination both within and between agencies. If the family planning program is
separate from the health department, this is even more problematic, as they often perceive
themselves as having very different missions.

Policy change
Openness, a general obstacle in this field, is particularly relevant with regard to policy
change. Communication is also important, whether between agencies or between government
and non-governmental sectors and researchers and academics. Donor/international community
equivocation may also be a continuing problem. Are our developing country colleagues still
getting mixed signals from the international community and donors with regard to the importance
of RTIs? In some countries, I think this continues to be the case. Finally, lack of research hinders
policy change, bringing us full circle to the obstacles to the development and conduct of research
presented above.
Esther Muia
The Population Council
Nairobi, Kenya

In conducting research on sexually transmitted diseases (STDs) in Kenya, we
encountered many of the obstacles discussed above. The project aimed to strengthen STD/HIV
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management. In the past, there were special STD clinics in Kenya and people were reluctant to
attend them due to the stigma involved. When they were required to bring their partners with
them, they would sometimes pay a stranger the equivalent of 50 cents to accompany them
instead. An additional problem related to the fact that many women did not have access to the
clinics, regardless of their limitations, for financial or social reasons.
We attempted to find a way to improve services in this environment and, after much
consideration, decided on an approach that would involve both communities and the clinics
themselves.
The community approach involved a focus on special groups, including adolescents and
prostitutes, who were given information on how to gain access to services and about the
symptoms of STDs. We also trained peer counselors to work with these special groups.
The clinic approach involved training more health care workers, including private
practitioners, and obtaining more supplies and drugs.
We developed and employed a syndromic approach to STD management because
existing lab facilities were not sufficient to enable us to test all clients. In addition, we devised
forms that aimed to reduce waiting time for partner diagnosis and treatment.
The main obstacles we faced related to personnel problems and lack of equipment—
including gloves, syringes, and drugs. Staff turnover was high, as providers felt that the project
was requiring them to do more than they were originally hired to do. We also lacked effective
supervisors. The socio-cultural obstacles related to the stigma attached to having or seeking
treatment for an STD remained problematic.
We had tried to involve policymakers from the start, but it became clear that some of
them had no idea what was going on. Some simply came to meetings and asked questions, but
did not seem to be interested in taking steps themselves. When we approached policymakers to
help pay for drugs to continue the project, many were reluctant. Our success in involving
policymakers, therefore, was uneven. As noted above, we need to find ways to strengthen the
link between researchers and policymakers so that when a research project is completed the
community will continue to receive improved services.
On a positive note, the procedures we developed are being adopted by the Ministry of
Health. However, it will be a long time before they are implemented because the Ministry must
secure funding for drugs. Perhaps if we had made stronger ties with policymakers from the start,
they could now be implemented more quickly.
Nandini Oomman
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Johns Hopkins University
School of Hygiene and Public Health
Baltimore, Maryland

I will present some of the obstacles we faced when we conducted our research on
ethnomedical models of vaginal discharge in India, which I described in detail earlier. Qualitative
and quantitative data collection was carried out in remote, desert villages in rural India, which
posed three types of obstacles:
Logistics Getting from one remote village to another was quite difficult. Because the
sites were so far away from each other, we had to live in villages for four days a week for four to
five months in order to gather data and get to know the women. We also had to set up clinics in
schools and could not transport specimens to a hospital or university laboratory in time to make
diagnoses. As local staff were not available, an entire research team had to be transported to
each site.
Socio-cultural issues Women's and men's knowledge of their bodies was quite limited,
and people were suspicious of gynecological examinations. Because women view discharge as
resulting from economic problems, they did not think that a physical examination could benefit
them.
Ethics It was not clear to us how we could, in this kind of environment, design a study to
determine reproductive tract infection (RTI) prevalence rates or recruit a random sample of
women. In addition, the research itself would raise the public's consciousness in this area, before
the data was used, and without any guarantee that related services would be provided. Because
the gynecological exam did not necessarily lead to treatment in women who felt they had, but
were found not to have, a problem, some women felt ignored or mistreated. Should such women
be given placebos or gifts?
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DEFINING THE RANGE OF FUTURE RESEARCH PRIORITIES AND INTERVENTIONS
Earmporn Thongkrajai
Community Health Development Project
Department of Medical and Surgical Nursing
Khon Kaen University
Khon Kaen, Thailand
Following are some research priorities that have emerged during our discussions.
· Consensus has not yet been reached on the consequences and scope of reproductive
tract infections (RTIs). Although much research has been done on these topics, more
is needed.
· RTI services need to be integrated with other health care services, including maternal
and child health (MCH) programs, so that individuals who seek or need them do not
feel stigmatized.
· We need to find ways to integrate RTI services with existing MCH and family planning
(FP) services more smoothly. At present, such efforts often result in health care
providers becoming overloaded and in high staff turnover.
· We need to develop interventions that take into account the fact that RTIs are not only
a medical problem, by looking closely at women's perceptions of their experiences,
including discharge or other symptoms that may not fit into our biomedical model. For
many women, RTIs are simply symptoms they do not understand and rarely get a
chance to talk about. We also need to examine and work on the attitudes of health
care providers in this regard. When a woman seeks help for symptoms that the
provider does not recognize, how does that make her feel? What are the
consequences?
· We must study the cultural factors that prevent women from talking about RTI-related
symptoms or seeking help, and develop interview techniques that use appropriate
questions to elicit this information.
· We need to know, on a context-specific basis, the types of traditional medicine that are
used by women when they experience such symptoms as discharge or pain during
urination.
· We must pay continued attention to the gender and empowerment issues related to RTI
care and prevention. In Thailand, for example, there are many cases of women who,
after becoming informed about AIDS, ask their partners to use condoms and are then
physically abused for making this request. We need to help such women find effective
and safe ways to negotiate with their partners.
· We need to continue to invest in the development of female-controlled technology.
· We need to conduct more research on RTIs and their relationship to AIDS.
· We must find ways to prolong the lives and improve the quality of life for those who are
terminally ill with AIDS. In Thailand, for example, we use meditation and some
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traditional herbal medicine to improve the quality of life for women with AIDS.

Adepeju Olukoya
Women's Health Organization of Nigeria
Lagos, Nigeria

We need more research on social science topics, including:
· gender and power relations and the decisionmaking that occurs "behind closed doors"
related to sexually transmitted diseases (STDs) and related protective measures;
· client acceptance of and attitude towards various types of service integration (family
planning and RTI services, for example);
· health workers' perceptions of RTIs; and
· the relationship between personal hygiene and infection, including menstrual
management and other practices that affect the genital tract.
There is an urgent need for biomedical research on topics related to reproductive tract infections
(RTIs), including:
· appropriate low-cost diagnostics and screening; and
· appropriate screening tools.
Research on other interventions is also needed, including:
· community education;
· broadly defined case management; and
· training of health care workers, including "unorthodox" peer counselors and traditional
birth attendants (TBAs).
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CLOSING SUMMARY

Beverly Winikoff and Christopher Elias
The Population Council
New York, New York

In closing, we will review the group's responses to the informal questionnaire (see
Appendix), which will, perhaps, articulate where we stand as a group in terms of our thinking on
reproductive tract infections (RTIs).

Importance of RTIs/STDs
There is a good deal of agreement that candida, bacterial vaginosis, and trichomonas are
the most widespread infections, that they are relatively easy to deal with, and that they are not the
most serious. This is a perfect case study for education and debate on public health issues.
What do you do when the infections that are easiest to treat pose the least serious health
problems? The group agreed that gonorrhea, chlamydia, syphilis, and human papilloma virus
(HPV) are more serious infections, but more expensive to diagnose and treat, and more difficult to
manage. Among these infections, syphilis and gonorrhea are the easiest to treat. There seems
to be a great deal of frustration about our inability to provide appropriate services. Few
participants talked about human immunodeficiency virus (HIV). Many focused on chlamydia, and
many on low-cost diagnostics.

Imagine you are a provider of IUD services. What STD/RTI services must you provide in
order to offer contraceptive services of an acceptable quality?
Thirteen participants responded that providers must be able to diagnose and treat RTIs in
order to provide contraceptive services of an acceptable quality. Four of these participants stated
that providers must be able to treat all RTIs. Ten respondents felt that providers must, at a
minimum, be able to treat gonorrhea (GC) and chlamydia, and some of these respondents also
stated that providers must also be able to diagnose and treat pelvic inflammatory disease (PID),
bacterial vaginosis, and "common RTIs" in order to provide quality services. Six participants
stated that providers must provide risk screening by history or behavioral criteria, clinical selection,
or self-screening. Information, education, and communication (IEC), pelvic exams, Pap smears,
and other "check-ups" were cited by one participant each. An additional participant included a
physical exam and cervical gram stain, and another indicated that the promotion of condom use
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for clients with more than one partner was necessary.

If you were providing family planning, but not the intrauterine device (IUD), would your
answer be different from the one given to the question above?
Seven participants responded in the affirmative and stated that fewer RTI-related services
would be needed to provide quality contraceptive services if the IUD were not offered. Five
participants said their answer would not change, and asserted that RTI diagnostic capacity must
be available in either case. Five participants said that the same level of service should be
provided regardless of whether or not the IUD was offered, but noted that providers should only be
responsible for performing clinical risk assessment if it was not. One participant said that more
services were needed if the IUD was not provided, including HPV, syphilis, and candida
screening, and another noted that the answer to this question would depend, presumably on other
factors related to RTI prevalence, and so forth.

Which is the most important RTI problem to be addressed?
Most participants felt that chlamydia should be given priority. Three participants said that
the development of low-cost diagnostic techniques was most important, and two that enhancing
awareness of RTIs, and IEC efforts, were most important. Septic abortion was the fourth most
commonly mentioned priority problem. Training, problems related to vaginal discharge, sexual
decisionmaking issues, syphilis, acceptable means of prevention, and PID were cited as the most
important problem by one participant each.

If you were torn when answering the above question and want to mention another
important problem, what would it be?
Three participants cited issues related to HPV and cervical cancer, two cited gonorrhea,
and prolapse, candida, PID, HIV, and low-cost diagnostics were cited by one participant each.
One participant raised a more conceptual problem: can we rely on risk assessment?

Which is the most important service to provide?
Six participants stated that RTI diagnosis and treatment is the most important service,
four cited counseling and information, three cited "screening" (although it is unclear whether this
meant case finding or risk assessment), two cited primary prevention, and the empowerment of
women and syphilis control were cited by one participant each.
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Which is the second most important service to provide?
Treatment, Pap smears, prenatal syphilis screening, development of laboratory capacity,
education, safe abortion, and screening were among the responses to this question.
Our discussions over the last two days have been lively, and we have heard a great deal
that has made us reevaluate our thinking related to RTIs. We have had the opportunity to talk
about a very complex set of issues with a variety of people from diverse organizations. More
questions have been raised than conclusions reached. Hopefully, we will be able to move forward
in our efforts to answer these questions, which include:

1. How do we use the tools and information from the quantitative and qualitative research
that has been conducted in both advocacy and program planning?
2. What do the results to date suggest about the approaches to service delivery that will
be most fruitful?
3. How should we modify the direction and/or type of research that we are conducting on
this topic?

Your continuing input on the third question will be of great use to us. Our impression is
that the Population Council's Robert H. Ebert Program needs to build on, and move beyond, its
work in this area: we have tended to focus on primarily descriptive studies and should move
toward intervention studies that are more directly involved with service provision. Other research
priorities include: examining health-seeking behavior related to RTIs; exploring ethnomedical
models of the way providers diagnose infections; and standardizing diagnostic procedures.
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APPENDIX
Questionnaire
Infection

Prevalence

Dx. Easy

Dx. Cheap

Rx. Easy

Rx. Cheap

Serious

Candida
B.V.
Trichomonas
Gonorrhea
Chlamydia
Syphilis
HPV
1. Using a scale from + for "a little" to ++++ for "a great deal," please rate each of these infections
according to the 6 characteristics above.

2.Imagine that you are a provider of IUD services. What STD/RTI services do you need to provide in
order to offer contraceptive services of acceptable quality?

3.Would your answer to #2, above, be different if you provided contraceptive services, but not the IUD?

4A. Which is the most important RTI problem to address? (Name one only)

B. Which is the most important RTI service to offer? (Name one only)

5.If you had trouble naming only one problem or service, above, here is your chance to name another.
(Complete only if you felt torn between choice.)
A. Another problem:
B. Another service:
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